Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             849 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A BEHAVIORAL ECONOMIC ANALYSIS OF POLYSUBSTANCE USE: STUDIES WITH COCAINE, FENTANYL, AND COCAINE–FENTANYL MIXTURES IN MALE AND FEMALE SPRAGUE-DAWLEY RATS Risca, Harmony

260 S p.
artikel
2 Abuse Potential Similarities Between Hypnotic Classes: Real-World Data Moline, Margaret

260 S p.
artikel
3 A Care Cascade Analysis of Opioid Use Disorder Services Provided in Jail Hoover, Daniel

260 S p.
artikel
4 Acceptability of Psychedelic Therapy Differs Among Social Workers, Psychiatrists, and Psychologists in the United States Armstrong, Stacey B.

260 S p.
artikel
5 Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders Kang, Augustine

260 S p.
artikel
6 ACCESS TO NO-COST PHARMACEUTICAL ALTERNATIVES TO ILLICIT DRUGS DURING INTERSECTING COVID-19 AND OVERDOSE HEALTH EMERGENCIES IN BRITISH COLUMBIA, CANADA: A QUALITATIVE STUDY McNeil, Ryan

260 S p.
artikel
7 Access to Tablet Injectable Opioid Agonist Therapy in Rural and Smaller Urban Settings in British Columbia: A Qualitative Study Bardwell, Geoff

260 S p.
artikel
8 A Cohort Sequential Analysis of Developmental Changes in Cannabis Use Practices and Problematic Cannabis Use Among Young Adult Users From Age 18 to 22 in Los Angeles Wong, Carolyn

260 S p.
artikel
9 A COLLABORATIVE CARE INTERVENTION TO PREVENT DEATH FROM OPIOID OVERDOSE AND SUICIDE AMONG THOSE WITH CO-OCCURRING DISORDERS Hindmarch, Grace

260 S p.
artikel
10 A Comparison of Non-Fatal Opioid Overdose, Acute Methamphetamine Toxicity, and Mixed Stimulant/Opioid Overdose Presentations: Implications for Measurement of Methamphetamine-Related Morbidity Wagner, Karla

260 S p.
artikel
11 A Consistent Decrease of Opioid Misuse Among Young Americans: A Pseudo-Cohort Analysis of Use Patterns From the National Household Survey on Drug Use and Health Bobashev, Georgiy

260 S p.
artikel
12 Actual Use Study of Nicotine Pouches Among U.S. Adult Smokers Parms, Tiffany

260 S p.
artikel
13 Acute Effects of Oral 3,4-Methylenedioxymethamphetamine (MDMA) and Delta-9-Tetrahydrocannabinol (THC) on Intrinsic Functional Connectivity Kearney-Ramos, Tonisha

260 S p.
artikel
14 Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy Davis, Alan

260 S p.
artikel
15 Adaptation of a Digital Intervention to Reduce Substance Use and Increase Contraceptive Access Among Women Involved in Criminal Legal Systems Slavin, Melissa

260 S p.
artikel
16 Adapting to the Fentanyl Epidemic: Rapid Qualitative Observations and Derived Protocol Modifications From the Emergency Department Longitudinal Integrated Care (ED-LINC) Randomized Clinical Trial Whiteside, Lauren

260 S p.
artikel
17 A Digital Health App for Opioid Treatment Programs: The Sonara Health Platform for Video Observed Methadone Take-Homes Giles, Michael

260 S p.
artikel
18 Adolescents’ Online Searches for Marijuana Information: Results From a Random Sample of Middle and High School Students in Los Angeles County Li, Shuwen

260 S p.
artikel
19 ADOLESCENTS’ STIMULANT THERAPY FOR ADHD AND LATER COCAINE AND METHAMPHETAMINE USE DURING YOUNG ADULTHOOD: A NATIONAL LONGITUDINAL STUDY McCabe, Sean Esteban

260 S p.
artikel
20 Adoption and Reach of Overdose Education and Naloxone Distribution in Kentucky During Wave 1 of the Healing Communities Study Knudsen, Hannah

260 S p.
artikel
21 ADVANCED CHARACTERIZATION OF ON- ELECTROCARDIOGRAPHIC (ECG) SENSORS’ DISCRIMINATORY POWER IN A HUMAN LABORATORY COCAINE SELF-ADMINISTRATION (SA) PARADIGM Angarita, Gustavo

260 S p.
artikel
22 Advantages and Disadvantages of Online Networking Among Those Engaged in Opioid Misuse Kasson, Erin

260 S p.
artikel
23 Adverse Childhood Experiences, Substance Use, and Mental Health Conditions Among Men who Have Sex With Men Chen, Lian-Yu

260 S p.
artikel
24 Aerobic Exercise During Adolescence Protects Against Anxiety Disorders in the United States Cordoba-Grueso, Whitney

260 S p.
artikel
25 Age and Pandemic-Related Stress Among Cannabis Consumers in First Year of COVID-19 Pandemic: Preliminary Results From the COVID-19 Cannabis Health Study Ibrahim, Layan

260 S p.
artikel
26 Age of Onset of Cannabis Use Predicts Anxiety, Psychoticism, and Anger-Hostility Mental Health Symptoms in Severe Concurrent Disorder Inpatients Thiessen, Karina

260 S p.
artikel
27 A HIGHLY G PROTEIN-BIASED MU OPIOID RECEPTOR AGONIST, SR-17018, HAS LOW IN VIVO EFFICACY IN PRIMATES Ko, Mei-Chuan

260 S p.
artikel
28 A Human Laboratory Study Investigating the Influences of Sex on the Acute Pharmacological Effects of a Range of Smoked Cannabis Doses Wright, Madison

260 S p.
artikel
29 AI/ML-Driven in Silico Identification of Blood-Brain Barrier Permeable Compounds Khotimchenko, Maksim

260 S p.
artikel
30 Alcohol Cue Reactivity in Virtual, Video Game Environments Regan, Timothy

260 S p.
artikel
31 Alcohol First, Cannabis Last: Identification of an Especially Risky Use Pattern Among Individuals who Co-Use Alcohol and Cannabis Karoly, Hollis

260 S p.
artikel
32 Alcohol Use and Substance Use Treatment Engagement Among Patients With Alcohol-Associated Cirrhosis in Three Hospital-Based Hepatology Practices Snyder, Hannah

260 S p.
artikel
33 A Longitudinal Analysis of Time in Buprenorphine Treatment States and Stratification by Hazardous Alcohol Use, Cocaine Use and Alcohol or Cocaine Use Disorders Among People With HIV Pytell, Jarratt

260 S p.
artikel
34 ALPHA 1 AND 2 NORADRENERGIC RECEPTORS AS TARGETS FOR REVERSING FENTANYL-INDUCED RESPIRATORY DEPRESSION Shaykin, Jakob

260 S p.
artikel
35 Am I in Recovery? Bayesian Network Analysis to Understand Mental Models of Adolescent Recovery Kosgolla, Janaka

260 S p.
artikel
36 A Mobile Health Tool to Capture Social Determinants of Health and Their Impact on HIV Treatment Outcomes Among People who Use Drugs Conway, Caitlin

260 S p.
artikel
37 A Multi-Phased Study to Develop a Novel Measure of Polysubstance Use Bunting, Amanda

260 S p.
artikel
38 AMYGDALA-PREFRONTAL CIRCUIT AS A POTENTIAL MEDIATOR OF REWARD SENSITIVITY IN NON-HUMAN PRIMATES Hur, Kwang-Hyun

260 S p.
artikel
39 Amyloid Pet and Diffusion Kurtosis Imaging for Alcohol Use Disorder Okita, Kyoji

260 S p.
artikel
40 An Analysis of Gender Differences in Cannabis Use Frequency Among People With Mental Health Disorders Pre- and Post-Recreational Cannabis Use Legalization: A Repeated Cross-Sectional Survey Sorkhou, Maryam

260 S p.
artikel
41 An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal Larochelle, Marc

260 S p.
artikel
42 An Evaluation of the “Critical Period” in Contingency Management Regnier, Sean

260 S p.
artikel
43 Anger Across Substance Use Disorders: Results From the National Epidemiologic Survey on Alcohol Use and Related Conditions-III Miloslavich, Krista

260 S p.
artikel
44 ANIMAL FORUM: THE 3RS CONCEPT OF REPLACEMENT: FUTURE TOOLS OR POLITICAL STRATEGY? Rowlett, James

260 S p.
artikel
45 An Implementation Science Framework to Contextualize an Innovative Intervention Integrating Medications for Opioid Use Disorders in the Probation System Bailey, Amelia

260 S p.
artikel
46 An Intervention Module for Methamphetamine Use in Youths Utilizing Mobile Smartphone Technology Wahab, Suzaily

260 S p.
artikel
47 An Intervention to Reduce the Stigma of Substance Use and Criminal Involvement Among Criminal Legal Staff: Feasibility, Acceptability, and Preliminary Effectiveness Moore, Kelly

260 S p.
artikel
48 An Observational Study of Medication for Opioid Use Disorder Prescribing Practices During Pregnancy Cioffi, Camille

260 S p.
artikel
49 A Novel Approach to Treat Fentanyl Intoxication Shetty, Shekar

260 S p.
artikel
50 A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone Timberlake, John

260 S p.
artikel
51 A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market Ashworth, Judy

260 S p.
artikel
52 An Overview of New Psychoactive Substances (NPS) Analysis and Trends in Taiwan, 2008-2022 Kang, Kai-Hsiang

260 S p.
artikel
53 ANXIETY TRAJECTORIES, WELL-BEING, AND CANNABIS USE IN A COHORT OF PENNSYLVANIA MEDICAL CANNABIS PATIENTS Ataiants, Janna

260 S p.
artikel
54 A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan Kou, Yen-Chun

260 S p.
artikel
55 A Pilot Trial of Integrated Intervention Strategies to Optimize Prep Care Among PWID in Rural Kentucky Surratt, Hilary

260 S p.
artikel
56 A Pilot Trial of Integrated Intervention Strategies to Optimize Prep Care Among PWID in Rural Kentucky Surratt, Hilary

260 S p.
artikel
57 Application of the Multiphase Optimization Strategy (MOST) to Optimize HIV Prevention Targeting People on Medication for Opioid Use Disorder (MOUD) who Have Cognitive Dysfunction: A Study Protocol Copenhaver, Michael

260 S p.
artikel
58 Applying the Observational-Implementation Hybrid Approach to Collect Implementation Data on the Use of Evidence-Based Practices to Support Reductions in Cannabis Use Among Black Sexual Minority Men and Transgender Women Knox, Justin

260 S p.
artikel
59 Applying Theory of Planned Behavior to Predict Online Addiction Treatment Intention During COVID-19 Bonny-Noach, Hagit

260 S p.
artikel
60 A Preliminary Evaluation of the Cost-Effectiveness of Long-Term Post-Treatment Peer Recovery Support Services in the United States Castedo de Martell, Sierra

260 S p.
artikel
61 A Preliminary Investigation of Repetitive Transcranial Magnetic Stimulation Applied to the Left Dorsolateral Prefrontal Cortex in the Treatment of Cannabis Use Disorder Sahlem, Gregory

260 S p.
artikel
62 A Prospective Investigation of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome Wightman, Rachel

260 S p.
artikel
63 A Prospective Study on Changes in Alcohol, Cannabis, and Tobacco Use From Before to During the COVID-19 Pandemic Megan Ross, J.

260 S p.
artikel
64 A Qualitative Study Examining Factors Influencing Access to Opioid Agonist Treatment Among a Sample of People who Use Drugs in Rural and Remote Canada Hodgson, Kate

260 S p.
artikel
65 A Retrospective Chart Review of Hormonal Contraceptives and Compliance With Medication for Opioid Use Disorder in Adolescents and Young Adults Mallahan, Stephanie

260 S p.
artikel
66 “ARRESTED DEVELOPMENT”? COCAINE PATIENTS WITH GENETICS LINKED TO OVER-RESPONSE OF THE STRESS (CORTISOL) SYSTEM SHOW AN “IMMATURE” PATTERN OF POSITIVE, RATHER THAN INVERSE, AMYGDALA RESTING FUNCTIONAL CONNECTIVITY WITH THE VMPFC Regier, Paul

260 S p.
artikel
67 A SOCIAL PEER RENEWS COCAINE SEEKING: POTENTIAL ROLE OF THE NUCLEUS ACCUMBENS Humburg, Bree

260 S p.
artikel
68 Aspects of Interorganizational Collaboration in Linking Justice-Involved Persons With Opioid Use Disorder Treatment: A Qualitative Exploration of the Community Supervision and Treatment Provider Relationship Perron, Lauren

260 S p.
artikel
69 Assessing Amygdala Habituation as it Relates to Substance-Use Disorder Vulnerability, Using Data From the ABCD Study® Regier, Paul

260 S p.
artikel
70 Assessing Provider Readiness to Implement Pre-Exposure Prophylaxis for HIV Prevention and Medications for Opioid Use Disorder Among People who Inject Drugs Pickering, Eleanor

260 S p.
artikel
71 Assessing the Add-On Impact of Accessibility Enhancement Program on the Alleviation of Participant Reduction in Methadone Maintenance Treatment Clinics in Taiwan: An Interrupted Time Series Analysis Chen, Wei J.

260 S p.
artikel
72 Assessing the Impact of Medical Expenditure Supplements Program on the Enrolling and Retention of Patients Attending Methadone Maintenance Treatment Clinics in Taiwan: An Interrupted Time Series Analysis Chung, Yu-Chu

260 S p.
artikel
73 ASSESSMENT OF THE SUBJECTIVE VALUE OF SOCIAL CONTEXT IN INDIVIDUALS WHO USE CANNABIS Shellenberg, Thomas

260 S p.
artikel
74 Association Between Ongoing Illicit Fentanyl Use and Risk for Non-Fatal Overdose Among Patients Treated With Opioid Agonist Therapy in Canada Lee, Kenneth

260 S p.
artikel
75 Association Between Prescribed Stimulant Medications and Overdose Among Individuals Receiving Opioid Agonist Therapy: A Retrospective Cohort Study From British Columbia, Canada Young, Samantha

260 S p.
artikel
76 Association Between Social Exposure and Substance Use Among Youth in the Legal System Yang, Yang

260 S p.
artikel
77 Association of Baseline Fentanyl Use and Opioid Withdrawal Symptoms During Inpatient Buprenorphine Initiation in a Large Multisite Detoxification Trial Shulman, Matisyahu

260 S p.
artikel
78 ASSOCIATION OF DOPAMINE D2-LIKE AND D3 RECEPTOR FUNCTION WITH INITIAL SENSITIVITY TO COCAINE REINFORCEMENT IN RHESUS MONKEYS Czoty, Paul

260 S p.
artikel
79 Association of Medications for Mood/Anxiety Disorders With Fatal and Non-Fatal Opioid Overdose Fairbairn, Nadia

260 S p.
artikel
80 Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence Bharat, Chrianna

260 S p.
artikel
81 Association of Prescribed Oral Stimulants on Cocaine Use Among Patients Enrolled in Opioid Agonist Treatment: A Retrospective Longitudinal Cohort Study Tatangelo, Mark

260 S p.
artikel
82 Associations Between Cigarette Smoking, Weight Status, and Mortality Among U.S. Adults Mestre, Luis

260 S p.
artikel
83 Associations Between Daily Coffee Consumption and Personal and Family Alcohol, Drug and Mental Health Problems in College Students: Looking Separately at Rapid and Slow Caffeine Metabolizers Svikis, Dace

260 S p.
artikel
84 ASSOCIATIONS BETWEEN GEOSOCIAL SEXUAL NETWORKING APP USE AND DRUG USE, PARTNER TYPE, AND SEXUAL BEHAVIORS AMONG SEXUAL MINORITY MEN DURING THE FIRST SHELTER-IN-PLACE ORDER OF THE CORONAVIRUS PANDEMIC IN TEXAS Loza, Oralia

260 S p.
artikel
85 Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin Lancelotta, Rafael

260 S p.
artikel
86 Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States Buttram, Mance

260 S p.
artikel
87 Associations Between Receipt of Government Assistance and Past-Year Substance Use Treatment Utilization Among People With Alcohol or Drug Use Disorders in the United States, 2015-2019 Gutkind, Sarah

260 S p.
artikel
88 Associations Between Suvorexant and Biological and Self-Reported Stress in a Randomized Trial in Persons With Opioid Use Disorder McKendrick, Greer

260 S p.
artikel
89 Associations of Sleep Quality and Perceived Stress With Discounting and Quality of Life in Substance Use Disorder Recovery Yeh, Yu-Hua

260 S p.
artikel
90 A STRUCTURAL EQUATION MODELING ANALYSIS OF ANTI-SOCIAL BEHAVIOR, SUBSTANCE MISUSE, TRAUMA, AND IRRITABILITY AMONG JUSTICE-INVOLVED ADOLESCENTS Wiedbusch, Elzbieta

260 S p.
artikel
91 A Summary of Opioid Recovery Funds: Settlements Between Pharmaceutical Companies and Governments Regarding Their Role in the Opioid Epidemic Jones, Jermaine

260 S p.
artikel
92 A Therapeutic Workplace for Adults With Alcohol Use Disorder who are Experiencing Homelessness Novak, Matthew

260 S p.
artikel
93 A Three Phase Program of Research Investigating a Digital Intervention for Substance Use Delivered via a Relational Agent, “Woebot” Robinson, Athena

260 S p.
artikel
94 A Time Series Analysis of Nonfatal and Fatal Drug Overdose Outcomes for the Surveillance of Drug Overdose Outbreaks Patton, Thomas

260 S p.
artikel
95 Attachment Insecurity Predicts Poly-Substance use in Individuals With Opioid Use Disorder Reporting Loneliness Snyder, Matthew

260 S p.
artikel
96 Attitudes and Beliefs About Vermont’s 2021 Buprenorphine Decriminalization Law Among Residents who Use Illicit Opioids Feder, Kenneth

260 S p.
artikel
97 Attitudes and Beliefs of Prenatal Cannabis Use: Assessing the Reliability of the Perceptions of Prenatal Cannabis Use Measure and Comparing Perceptions Between Locations Wiese, Anna

260 S p.
artikel
98 Attitudes Toward Naloxone Uptake for Opioid Overdose Prevention Among People who Use Opioids in the Southeastern U.S. Le, Mylinh

260 S p.
artikel
99 Auditing Measures of Harmful Alcohol Use in Transgender and Non-Binary Communities: A Systematic Review Motemayor, Ana Chapa

260 S p.
artikel
100 A Virtual Reality Recovery Support Intervention for Opioid Use DISORDER: Efficacy Testing and Development Oberlin, Brandon

260 S p.
artikel
101 Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults Campbell, Kaytryn

260 S p.
artikel
102 Avoiding Naloxone-Induced Precipitated Withdrawal: A Procedure for Studying Opioid Negative Reinforcement in Rats Pitts, Kayla

260 S p.
artikel
103 Ayahuasca-Assisted Addiction Treatment in Peru: Results, Challenges, and Promises From a Multi-Year, Mixed-Methods Study at Takiwasi Center Marcus, Olivia

260 S p.
artikel
104 AYAHUASCA SELF-ADMINISTRATION USING A TWO-BOTTLE CHOICE PROCEDURE IN MALE MICE Serra, Yasmim

260 S p.
artikel
105 Bacterial and Fungal Infections: An Underrecognized Cause of Death Among People With Drug Use Diagnoses Figgatt, Mary

260 S p.
artikel
106 Barriers and Facilitators to Expanding Buprenorphine Treatment for Opioid Use Disorder in Jail Settings Kelsch, Jordan

260 S p.
artikel
107 Barriers and Facilitators to Integrating Medications for Opioid Use Disorder (MOUD) and HIV Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults (AYA) Herrera, Maria

260 S p.
artikel
108 Barriers and Facilitators to the Prescription Monitoring Program in Harris County, TX: Preliminary Findings Betancur, Alejandro

260 S p.
artikel
109 BARRIERS AND OPPORTUNITIES TO LINK PEOPLE RELEASED FROM CLOSED-SETTING REHABILITATION CENTERS TO COMMUNITY-BASED SERVICES IN VIETNAM Nguyen, Trang

260 S p.
artikel
110 Barriers to Enrolling Monolingual Spanish-Speaking Primary Care Patients in a Screening and Brief Intervention (SBI) RCT to Reduce Risky Drug Use: Lessons Learned From the Quit-Mobile Study Cazares, Leticia

260 S p.
artikel
111 Barriers to Retention in Inpatient and Residential Drug Treatment Among Persons who Use Opioids in the Rural U.S. Mixson, Lyndsey

260 S p.
artikel
112 Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic Flannagan, Kerry

260 S p.
artikel
113 BEHAVIORAL ASSESSMENTS AND NEUROCHEMICAL ASSAYS DIFFERENTIATE THE EFFECTS OF 1-(1-BENZOFURAN-5-YL)-2-(METHYLAMINO) PROPAN-1-ONE HYDROCHLORIDE (BK-5-MAPB) ENANTIOMERS Johnson, Candace

260 S p.
artikel
114 Benzodiazepine, Z-Drug, and Sleep Medication Prescriptions in Male and Female People With Opioid Use Disorder and Comorbid Insomnia: An Analysis of Multi-State Insurance Claims Martin, Caitlin

260 S p.
artikel
115 Black Market Drug Purchases as Reported to Real-Time Monitoring Website, StreetRx Kritikos, Brooke E.

260 S p.
artikel
116 Body Mass Index in Alcohol Withdrawal: Predictive or Protective? Ely, Alice

260 S p.
artikel
117 Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement Reif, Sharon

260 S p.
artikel
118 Brief Xenon Gas Inhalation Attenuates Naltrexone-Precipitated Morphine Withdrawal Symptoms in Morphine-Dependent Mice Kaufman, Marc

260 S p.
artikel
119 Buprenorphine Decreases Fentanyl Vapor Self-Administration More Effectively in Opioid Dependent Rats Frye, Emma

260 S p.
artikel
120 Buprenorphine-Naloxone vs. Extended-Release Naltrexone for Opioid Use Disorder in People With Recent Criminal Legal Involvement: A Secondary Analysis of the X:BOT Randomized Controlled Trial Balter, Dylan

260 S p.
artikel
121 Buprenorphine Versus Methadone for the Treatment of Opioid Dependence: A Systematic Review and Meta-Analysis of Randomised and Observational Studies Degenhardt, Louisa

260 S p.
artikel
122 Bystander Preference for Naloxone Products Marks, Katherine

260 S p.
artikel
123 Calcium Imaging of Central Amygdala Activity After Escalation of Fentanyl Self-Administration Malone, Samantha

260 S p.
artikel
124 California's Drug Medi-Cal Organized Delivery System Implementation: Substance Use Services Evolution From 2017-2021, Key Lessons Learned and Systems Improvements From the 1115 Demonstration Project Khalsa, Rama

260 S p.
artikel
125 CANNABINOID CONTENT AND LABEL ACCURACY OF VARIOUS HEMP-DERIVED COSMETIC AND FOOD/BEVERAGE PRODUCTS AVAILABLE ONLINE AND AT NATIONAL RETAIL STORES Dowd, Ashley

260 S p.
artikel
126 CANNABINOID-INVOLVED EXPOSURES, ED VISITS AND HOSPITALIZATIONS BEFORE AND AFTER ARKANSAS MEDICAL MARIJUANA LAW ENACTMENT: INITIAL TRENDS Oliveto, Alison

260 S p.
artikel
127 Cannabinoid Research at the NIH Shurtleff, David

260 S p.
artikel
128 Cannabis Reduction is Associated With Improved Functional Outcomes: An Aggregated Analysis From Seven Cannabis Treatment Trials McClure, Erin

260 S p.
artikel
129 Cannabis Research Priorities at the National Institute on Drug Abuse Weiss, Susan

260 S p.
artikel
130 Cannabis Retail Staff Perspectives on Trustworthiness of Social Media Information: A Qualitative Study Meacham, Meredith

260 S p.
artikel
131 Cannabis Use and Mental Health Coping Behavior Among Minority Women During the COVID-19 Pandemic: Results From the COVID-19 Cannabis Health Study Diggs, Bria-Necole

260 S p.
artikel
132 Cannabis Use Disorder Symptom Profiles Among Individuals Reporting Past-Year Cannabis Use in the United States DeVeaugh-Geiss, Angela

260 S p.
artikel
133 Cannabis Use Disorder Treatment Preferences: A Pilot Survey in People who Currently Use Cannabis Lile, Joshua

260 S p.
artikel
134 Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users Krause, Alexis

260 S p.
artikel
135 Cannabis Use for Medical Symptoms: Patterns Over the First Year of Use Gilman, Jodi

260 S p.
artikel
136 Cannabis Use Frequency’s Positive Associations With Blood Pressure Among Young Adult African American Students Morris, Alexis

260 S p.
artikel
137 Cannabis Use in Adolescence and the Later Onset of Bipolar Disorder: A Systematic Review and Meta-Analysis of Prospective Cohort Studies Yasuma, Naonori

260 S p.
artikel
138 Caregiver Recommendations for Contingency Management in Juvenile Probation Jackson, Logan

260 S p.
artikel
139 CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY Nuñez, Stephanie

260 S p.
artikel
140 Care Utilization Among Patients With Stimulant Use Disorder During COVID-19: A National Cohort Study of U.S. Veterans Lin, Lewei (Allison)

260 S p.
artikel
141 “CATCHING CHARGES SAVED MY LIFE”: EXPLORING COMMUNITY PERSPECTIVES ON THE ROLES PLAYED BY THE CRIMINAL LEGAL SYSTEM IN ADDRESSING OPIOID USE DISORDER Booty, Marisa

260 S p.
artikel
142 Challenges Linking Clients to Medication for Opioid Use Disorder (MOUD) From Emergency Department (ED) Settings Gallivan, Molly

260 S p.
artikel
143 CHANGES IN ANALGESIC AND ABUSE-RELATED EFFECTS OF CANNABIS WITH REPEATED ADMINISTRATION IN HUMANS Arout, Caroline

260 S p.
artikel
144 Changes in Buprenorphine Prescribing After X-Waiver Exemptions: An Interrupted Time Series Analysis Roy, Payel

260 S p.
artikel
145 Changes in Cannabis Use, Nicotine Dependence, and Cigarette Cessation Among U.S. Adult Cigarette Smokers by State-Level Legalization of Non-Medical Cannabis, 2013-2019 Driezen, Peter

260 S p.
artikel
146 Changes in Mentalization, Cognition, and Catastrophizing Scores During Methadone Maintenance Treatment Peles, Einat

260 S p.
artikel
147 Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis Picco, Louisa

260 S p.
artikel
148 Changes in Opioid and Other Analgesic Prescribing Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis Nielsen, Suzanne

260 S p.
artikel
149 Changes in Prevalence of Substance Use Among Patients of Community Health Centers in Los Angeles Over Time: Comparative Analysis From 2013 to 2022 Hernandez-Casas, Daisy

260 S p.
artikel
150 CHANGES IN STATE-LEVEL MEDICAL AND RECREATIONAL CANNABIS LAWS AND CANNABIS USE OUTCOMES BY SEXUAL IDENTITY AND GENDER FROM 2015-2019 Philbin, Morgan

260 S p.
artikel
151 Changes in Use of Cigarettes, e-Cigarettes, Alcohol, and Cannabis Among U.S. Adults According to State-Level Legalization of Non-Medical Cannabis, 2013-2019 Smith, Danielle

260 S p.
artikel
152 Changing Characteristics of HIV/AIDS Epidemic in Malaysia Kasinather, Vicknasingam

260 S p.
artikel
153 Characteristics Associated With Cannabis Dispensary Purchasing Among a Representative Sample of Adults in the United States who Use Cannabis Myers, Matthew

260 S p.
artikel
154 Characteristics Associated With Opioid Use Disorder Care Post-COVID-19 Public Health Emergency: A Cohort Study Bailey, Steffani

260 S p.
artikel
155 Characteristics of Adults Who Used Opioids Nonmedically From the NDEWS Rapid Street Reporting, 2021 to 2022 Wang, Anna

260 S p.
artikel
156 Characteristics of People With Early Psychosis and Substance Use Problems Liew, Megan

260 S p.
artikel
157 Characteristics of Substance Use Disorder Treatment Facilities That Provide Tailored Mental Health Treatment Ware, Orrin

260 S p.
artikel
158 Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process Moreland, Angela

260 S p.
artikel
159 CHARACTERIZING BIASED MU-OPIOID RECEPTOR AGONISTS, PZM21 AND SR17018 IN SELF-ADMINISTRATION, AND WHOLE- PLETHYSMOGRAPHY IN RATS Pham, Loc

260 S p.
artikel
160 Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention Ludwig-Barron, Natasha

260 S p.
artikel
161 Characterizing Medical Cannabis Use Among Medical Users in Florida Using Cannabis for Sleep Reasons and Reporting Poor Sleep Perez-Carreno, Juan G.

260 S p.
artikel
162 Characterizing Methamphetamine Use Among Opioid Agonist Therapy-Seeking Adults With Prescription-Type Opioid Use Disorder in Canada Langlois, Jenna

260 S p.
artikel
163 Childhood Aggression and Adolescent Substance Use Initiation Satybaldiyeva, Nora

260 S p.
artikel
164 Chronic Alcohol Self Administration Induces Extracellular Matrix Abnormalities in the Hippocampus of Non-Human Primates Valeri, Jake

260 S p.
artikel
165 Chronic Disease Symptoms Self-Managed With Cannabis During the COVID-19 Pandemic: Results From the COVID-19 Cannabis Health Study O'Dell, Nicole

260 S p.
artikel
166 CHRONIC METHAMPHETAMINE ADMINISTRATION TO MALE MICE PRODUCES AXONAL LOSS PRIOR TO SOMATIC LOSS IN NORADRENERGIC LOCUS COERULEUS NEURONS Pilski, Alexander

260 S p.
artikel
167 Chronic Nicotine Use Induces a Unique Neuroimmune Landscape That Critically Impacts Aberrant Accumbens Synaptic Plasticity Bondy, Emma

260 S p.
artikel
168 CHRONIC PROGESTERONE TREATMENT REDUCES NICOTINE CONSUMPTION AND ACCUMBENS MICROGLIAL MORPHOMETRICS IN A SEX-SPECIFIC FASHION Kendrick, Percell

260 S p.
artikel
169 CHRONIC THC EXPOSURE DURING ADOLESCENCE PRODUCES PERSISTENT ECONOMIC DEMAND ABNORMALITIES IN ADULT NONHUMAN PRIMATES Kangas, Brian

260 S p.
artikel
170 Cigarette and E-Cigarette Use Trajectories and Prospective Prescription Drug Misuse Among Adolescents and Young Adults Harton, Moriah

260 S p.
artikel
171 Cigarette Smoking and Executive Function: Experimental Effects of Very-Low-Nicotine-Content Cigarettes Katz, Brian

260 S p.
artikel
172 Cigarillo Purchasing and Pack Sizes by Their Use as Blunts Fairman, Brian

260 S p.
artikel
173 Clinical Profiles of Individuals With Primary Heroin and Primary Prescription Opioid Use Witcraft, Sara

260 S p.
artikel
174 COCAINE SELF-ADMINISTRATION BEHAVIOR IS ASSOCIATED WITH SUBCORTICAL AND CORTICAL GRAY MATTER IN INDIVIDUALS WITH COCAINE USE DISORDER Kohler, Robert

260 S p.
artikel
175 Combinations of Drugs Among Maryland Overdose Decedents Tomko, Catherine

260 S p.
artikel
176 Combined Multiomics of Comorbid Alcohol Use Disorder and Depression Vallender, Eric

260 S p.
artikel
177 COMING OUT TO TREATMENT: CHARACTERIZING EXPERIENCES OF SEXUAL AND GENDER MINORITIZED INDIVIDUALS IN SUBSTANCE USE DISORDER TREATMENT BEFORE AND DURING THE COVID-19 PANDEMIC Sadicario, Jaclyn

260 S p.
artikel
178 Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort Adams, Faith

260 S p.
artikel
179 Common Barriers to Risky Cannabis Use Reduction Among Adult FQHC Primary Care Patients in Los Angeles County Vo, Quynh

260 S p.
artikel
180 Community Focused Technical Assistance: A Multifaceted Approach to Address Opioid-Related Overdoses Lauckner, John

260 S p.
artikel
181 Comparing mHealth Use and Acceptability in Individuals Engaged in Treatment for Substance Use Disorders Prior to and After the Start of COVID-19 Levine, Emily A.

260 S p.
artikel
182 Comparison Between Original and Adaptive Form of Cocaine Purchase Task Quddos, Fatima

260 S p.
artikel
183 COMPARISON OF BEHAVIORAL EFFECTS OF NOVEL DESIGNER DRUGS IN MALE RODENTS Shetty, Ritu

260 S p.
artikel
184 Comparison of Symptom Networks in Younger Adults vs. Middle and Older Adults With Past 12-Month Non-Medical Use of Prescription Pain Relievers Falise, Alyssa

260 S p.
artikel
185 Comparisons Between Prescription Opioid Formulations and Risk for New-Onset Affective Disorders in Chronic Pain Patients Houghton, David

260 S p.
artikel
186 COMPUTATIONAL MODELING OF EFFORT-BASED DECISION MAKING IN COCAINE USE DISORDER Basaldu, Diego

260 S p.
artikel
187 Concurrent and Prospective Relations Between Aberrant Stress-Induced Frontal Alpha Asymmetry and Cannabis Use Disorder Schermitzler, Brandon

260 S p.
artikel
188 CONCURRENTLY AVAILABLE NEGATIVE REINFORCEMENT DECREASES COCAINE SELF-ADMINISTRATION IN RATS Marcus, Madison

260 S p.
artikel
189 Connection, Navigation, Engagement in Care and Treatment (ConNECT) for Opioid Use Disorder Al-Tayyib, Alia

260 S p.
artikel
190 Co-Occurrence of Cannabis Use and Cigarette Smoking Accelerates Epigenetic Age Bradley, Brooklyn

260 S p.
artikel
191 Co-Occurrence of Gaming Disorder and Drug Dependence in People who Use Stimulants During the Era of COVID-19 Pandemic in Taiwan Lee, Tony Szu-Hsien

260 S p.
artikel
192 Cooling Flavors Use and E-Cigarette Nicotine Dependence Among Youth Li, Wei

260 S p.
artikel
193 Correlates of Methamphetamine Use for Self-Treatment of Attention Deficit/Hyperactivity Disorder Timmons, Patricia

260 S p.
artikel
194 Correlates of Resilience in Transitional Age Youth Experiencing Homelessness Burke, Colin

260 S p.
artikel
195 Counselor Terminological Preferences for "Craving,” “Euphoria,” and “Withdrawal” Among Patients Receiving Methadone Treatment Gazzola, Marina Gaeta

260 S p.
artikel
196 Co-Use of Harm Reduction and Addiction Treatment Services Associated With Decreased Non-Fatal Overdose in Catalonia Korthuis, Todd

260 S p.
artikel
197 COVID-19 Vaccination and HIV Transmission Among Persons who Inject Drugs During the First Two Years of the COVID-19 Pandemic in New York City Jarlais, Don Des

260 S p.
artikel
198 Craving Persistence Over 3 Months: An Early and Predictive Marker of Addiction? Baillet, Emmanuelle

260 S p.
artikel
199 Criminal Justice Involvement as Trauma: The Role of Recidivism and Reentry on Substance Use Trajectories Among Women With Substance Use Disorders Strong-Jones, Sienna

260 S p.
artikel
200 Cross-Spouse Relationships Between Drug Use and Marital Functioning Among Reserve and National Guard Soldiers and Their Spouses Vest, Bonnie

260 S p.
artikel
201 Cumulative Vulnerabilities: An Investigation of Lifetime Substance Use Among Individuals in Recovery From Opioid Use Disorder Tomlinson, Devin

260 S p.
artikel
202 Delay Discounting, Pain Catastrophizing, and Quality of Life Among Individuals in Recovery From Substance Use Disorder: A Reinforcer Pathology Perspective Dwyer, Candice

260 S p.
artikel
203 Depression Profiles and Hepatitis C Treatment Outcomes Among Persons who Inject Drugs: The Hero Study Lopes, Snehal

260 S p.
artikel
204 DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM Yeh, Hsueh-Han

260 S p.
artikel
205 DEVELOPING AN APP TO PROVIDE CBT FOR VAPING CESSATION TO YOUTH E-CIGARETTE USERS Kong, Grace

260 S p.
artikel
206 Developing a Novel High-Fidelity Overdose Simulation Model Brandt, Laura

260 S p.
artikel
207 Developing Core Consensus Measures for Assessment of Psilocybin Services Korthuis, P. Todd

260 S p.
artikel
208 Development and Clinical Feasibility of an Abbreviated Addiction-Focused Phenotyping Battery Piloted in a Female OUD Sample Receiving Buprenorphine Treatment Parlier-Ahmad, Anna

260 S p.
artikel
209 Development and Validation of a “Reasons for Electronic Cigarette Use” Questionnaire Ledgerwood, David

260 S p.
artikel
210 Development, Calibration, and Delivery of Personalized Cognitive-Behavioral Interventions Through Software Siegel, Gregg

260 S p.
artikel
211 Development of a Community-Based Wastewater Surveillance System to Measure Opioid, Stimulant and Medications for Opioid Use Disorder in the COVID-19 Pandemic Chai, Peter

260 S p.
artikel
212 Development of Dual “Atypical” DAT Inhibitor/Sigma Receptor Antagonists as Novel Treatments for Stimulant Use Disorder Reich, Jeffrey

260 S p.
artikel
213 Development of Dual MOR Agonist/DOR Antagonists as Novel Treatments for Opioid Use Disorder Pasternak, Annie

260 S p.
artikel
214 Development of Text Message-Based Intervention Content for People who Inject Drugs: Opportunities and Challenges Aronson, Ian

260 S p.
artikel
215 Diabetes Management in Patients With Substance Use Disorder Served in a Network of Federally Qualified Health Centers in Florida: A Retrospective Analysis Using EHR Data Horigian, Viviana

260 S p.
artikel
216 DIET-INDUCED CHANGES IN NICOTINE VAPOR SELF-ADMINISTRATION AND METABOLIC MARKERS IN C57BL/6J MICE Tetteh-Quarshie, Samuel

260 S p.
artikel
217 Differences in Acute and Enduring Effects of MDMA vs. Classic Psychedelics in People With Eating Disorders Gukasyan, Natalie

260 S p.
artikel
218 Differences in Hepatitis C Virus (HCV) Testing and Treatment by Opioid, Stimulant, and Polysubstance Injection Among People who Inject Drugs (PWID) in Rural U.S. Communities Estadt, Angela

260 S p.
artikel
219 Differences in Immediate Memory Performance Between Individuals Living With and Without Cannabis Use Disorder in Young Adult HBCU Undergraduates Quarles, Emma

260 S p.
artikel
220 Differences in Psychopathology, Substance Use, and Social Support Among Adolescents With Versus Without Lifetime Alcohol Use Vidal, Carol

260 S p.
artikel
221 DIFFERENCES IN PSYCHOSTIMULANT INTAKE LEVELS DO NOT NECESSARILY CORRESPOND TO DIFFERENCES IN MOTIVATION FOR THE DRUG Castaneda, Diego Martinez

260 S p.
artikel
222 Differential Reward Processing Across Adolescent Temperamental Profiles Associated With Increased Risk of Substance Use Perez, Patricio Viera

260 S p.
artikel
223 Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications Lanier, Ryan

260 S p.
artikel
224 DIRECT PATHWAY SPINY PROJECTION NEURON INTRINSIC EXCITABILITY IS INCREASED IN THE DORSOLATERAL STRIATUM DURING ACUTE BUT NOT PROTRACTED ABSTINENCE FROM METHAMPHETAMINE SELF-ADMINISTRATION Choi, Sanghoon

260 S p.
artikel
225 Discriminative Stimulus and Antinociceptive Effects of Six Novel Fentanyl Analogs Gatch, Michael

260 S p.
artikel
226 Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder Biondi, Breanne

260 S p.
artikel
227 Disparities in Use of Syringe Services Programs in King County, WA Salow, Katheryn

260 S p.
artikel
228 Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers Kirtadze, Irma

260 S p.
artikel
229 DO OVARIAN HORMONES MODULATE THE EFFECT OF DELTA-9-TETRAHYDROCANNABINOL (THC) ON INHIBITORY CONTROL IN WOMEN? Pabon, Elisa

260 S p.
artikel
230 Do People With Substance Misuse (SM) Use Distinct Pain Treatment Modalities? Rosen, Marc

260 S p.
artikel
231 DOSE-DEPENDENT EFFECTS OF SMOKED CANNABIS ON SIMULATED DRIVER PERFORMANCE: PRELIMINARY FINDINGS Brands, Bruna

260 S p.
artikel
232 DOSE EFFECTS OF ORAL AND VAPORIZED DELTA-8-THC AND COMPARISON TO DELTA-9-THC IN HEALTHY ADULTS Vandrey, Ryan

260 S p.
artikel
233 Drug Checking in the Fentanyl Era: Awareness, Interest, and Utilization Among People who Inject Drugs in San Diego County, California Bailey, Katie

260 S p.
artikel
234 Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity Rouhani, Saba

260 S p.
artikel
235 Drug Overdose Risk Following Benzodiazepine Treatment in Young Adults With Depression or Anxiety Disorders Bushnell, Greta

260 S p.
artikel
236 Dynamic Modeling on the Health Outcomes for People With First-Time Offense of Different Illicit Drugs in Taiwan With Implications for Policy Chen, Chi-Ya

260 S p.
artikel
237 Earlier Substance Use and Differential Rates by Substance Class for Youth With Combined Externalizing Disorders and Family History of Substance Use Disorders Smoker, Michael

260 S p.
artikel
238 Early Non-Adherence Among Individuals Initiating Low Barrier Buprenorphine Treatment in an Office-Based Setting Dugosh, Karen

260 S p.
artikel
239 EDDY LECTURE: WHAT HAS BRAIN IMAGING TAUGHT US ABOUT STIMULANT USE DISORDER London, Edythe

260 S p.
artikel
240 Editorial Board
260 S p.
artikel
241 Effectiveness of Family Intervention Addressing Expressed Emotions in Recipients of Opioid Substitution Therapy: A Randomised Controlled Study Singh, Vasudha

260 S p.
artikel
242 Effectiveness of Rapid Inpatient Initiation of Methadone for Pregnant Women With Opioid Use Disorder Hand, Dennis

260 S p.
artikel
243 Effect of Acute THC, Sex, and Lifetime Cannabis Use on Neural Reward Activation Denson, Rebecca

260 S p.
artikel
244 EFFECT OF CANNABIDIOL ON SUBJECTIVE INDICES OF MORPHINE ABUSE LIABILITY Thomas, Halle

260 S p.
artikel
245 Effects of a Comprehensive Patient Navigation Program on High-Cost Healthcare Utilization Among Patients Enrolled in Project HOUDINI LINK (Hospital Opioid Use Disorder treatment INItiation and LINKage to Care) Islam, Kendall

260 S p.
artikel
246 EFFECTS OF BENZODIAZEPINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS ON MIDAZOLAM SELF-ADMINISTRATION IN RHESUS MONKEYS Berro, Lais

260 S p.
artikel
247 EFFECTS OF BUSPIRONE PRETREATMENT ON OXYCODONE VS. MILK “CHOICE” SELF-ADMINISTRATION IN NON-HUMAN PRIMATES Razavi, Yasaman

260 S p.
artikel
248 Effects of Cannabidiol and Morphine on Antinociception Across Multiple Modalities Lundahl, Leslie

260 S p.
artikel
249 Effects of Chronic Naltrexone Treatment on Relapse-Related Behavior and Neural Responses to Fentanyl in Awake Squirrel Monkeys Withey, Sarah

260 S p.
artikel
250 Effects of Co-morbid Health Conditions on Health-Related Quality of Life Among Recovery Residents With an Opioid Use Disorder in Texas Obekpa, Elizabeth

260 S p.
artikel
251 EFFECTS OF GABAPENTINOIDS ON HEROIN SELF-ADMINISTRATION IN MALE AND FEMALE RATS Flynn, Shawn

260 S p.
artikel
252 Effects of Nicotine Dose in Cigarettes on Symptoms of Depression and Anxiety Gaalema, Diann

260 S p.
artikel
253 Effects of Opioids on the Synaptic Density in Rodents: A Systematic Review and Meta-Analysis Oliva, Henrique

260 S p.
artikel
254 Effects of Opioid Use Disorder and Withdrawal on Striatal Reward Prediction Errors During Decision-Making Wesley, Michael

260 S p.
artikel
255 Effects of Target Self-Selection in an App-Based Contingency Management Intervention to Reduce Substance Use Fletcher, Jesse

260 S p.
artikel
256 Effects of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain: A Scoping Review Warren, Katherine

260 S p.
artikel
257 EFFECTS OF UNSCHEDULED BENZODIAZEPINES IN A MIDAZOLAM DISCRIMINATION ASSAY Paronis, Carol

260 S p.
artikel
258 EFFICACY OF EXTENDED-RELEASE INJECTABLE BUPRENORPHINE FOR PATIENTS WITH DUAL OPIOID AND COCAINE USE DISORDER Marsden, John

260 S p.
artikel
259 Emerging Sex Differences in Current Tobacco and Marijuana Use Trends Among Members of a Community Engagement Program in Florida Seegulam, Vijaya

260 S p.
artikel
260 Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders Todesco, Stefanie

260 S p.
artikel
261 Emotion Regulation Expectancies and Smoking Cessation Factors: An Ecological Momentary Assessment Study During a Practice Quit Attempt Pang, Raina

260 S p.
artikel
262 EMS Calls for Naloxone Administration and Implementation of EMS-Specific Overdose Prevention Strategies Across Maryland Tomko, Catherine

260 S p.
artikel
263 Engagement in OUD Treatment 6 Months After Community-Based Intervention Denis, Cecile

260 S p.
artikel
264 Enhancing Integration of Substance Use Research Among BIRCWH Scholars: The BIRCWH Scholars Innovation Program (BSIP) Needs Assessment Hartwell, Karen

260 S p.
artikel
265 Essential Experimental Screening to Evaluate the Safety of Novel Psychedelics Gosden, Jane

260 S p.
artikel
266 Establishing and Engaging Community Partner Boards That Generate the Research Ideas Drazdowski, Tess

260 S p.
artikel
267 Estimating Human Doses of Stimulant-Like New Psychoactive Substances Based on Invitro Monoamine Transporter Data Baggott, Matthew

260 S p.
artikel
268 Estimating the Impact of Diverted Buprenorphine on Population Opioid Overdose Incidence Using an Agent-Based Model Adams, Joella

260 S p.
artikel
269 Estradiol Enhances the Development of Addition-Like Features in a Female Rat Model of Opioid Use Disorder Towers, Eleanor

260 S p.
artikel
270 Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder Weiss, Roger

260 S p.
artikel
271 Evaluating Changes in Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder Before and During the COVID-19 Pandemic Nguyen, Anh

260 S p.
artikel
272 EVALUATING CLAVULANIC ACID FOR TREATMENT OF COCAINE USE DISORDER Maser, Joya

260 S p.
artikel
273 EVALUATING INFLUENTIAL FEATURES OF SOCIAL MEDIA POSTS ADVERTISING ILLICIT DRUGS USING CONJOINT ANALYSIS Haupt, Michael

260 S p.
artikel
274 Evaluating Patient Perspectives on Mixed Virtual and In-Person Group Settings Oesterle, Tyler

260 S p.
artikel
275 EVALUATING THE FEASIBILITY AND PRELIMINARY EFFICACY OF A REAL-TIME SMOKING INTERVENTION USING WEARABLE TECHNOLOGY Bold, Krysten

260 S p.
artikel
276 Evaluation of a Functional Assessment Tool for Alcohol Use Traxler, Haily

260 S p.
artikel
277 EVALUATION OF CANNABIDIOL (CBD) AS A POTENTIAL MEDICATION FOR ALCOHOL USE DISORDER (AUD) – RESULTS FROM A PRECLINICAL DRINKING MODEL IN BABOONS Weerts, Elise

260 S p.
artikel
278 Evaluation of the Pharmacokinetic and Pharmacodynamic Profile of Cannabigerol (CBG) in Human Subjects Wolinsky, David

260 S p.
artikel
279 Evaluation of the Risk of Psychoactive Substance Use and Eating Attitudes and Behaviors Among Palestine Refugees in the North of the West Bank Shakhshir, Ali

260 S p.
artikel
280 Examining Drug Overdose Mortality Ratios and Their Intersection With Substance Use Disorder-Related Services Across Diverse Communities in a Segregated Metropolitan Area Mohebbi, Fahimeh

260 S p.
artikel
281 Examining Polysubstance Overdose Patterns and Demographic Correlates: A Latent Class Analysis in St. Louis, Missouri Richardson, Julia

260 S p.
artikel
282 Examining Population Trends in the Association Between Mental Health and Psychedelic Use Grossman, Daniel

260 S p.
artikel
283 Examining Protective Behavioral Strategies and Harm Reduction Service Utilization Among Individuals who Use Opioids Luba, Rachel

260 S p.
artikel
284 Examining Quality of Life in a Sample of U.S. Veterans Seeking Treatment for Substance Use Stanton, Cory

260 S p.
artikel
285 EXAMINING RACIAL DIFFERENCES IN SMOKING-RELATED OUTCOMES IN HUMANS DURING EARLY ABSTINENCE AND AFTER INTRAVENOUS NICOTINE INFUSION Schwartz, Elizabeth

260 S p.
artikel
286 Examining the Effects of Marijuana Use on Cognition in Persons With and Without HIV Towe, Sheri

260 S p.
artikel
287 Examining the Relationship Between Childhood Trauma and Behavioral Economic Indices Among Individuals Who use Opioids Ferreiro, Andrea Vasquez

260 S p.
artikel
288 Examining the Relationship of Concurrent Obesity and Tobacco Use Disorder on the Development of Substance Use Disorders and Psychiatric Conditions: Findings From the NESARC-III Fields, Logan

260 S p.
artikel
289 Expanding Medication for Opioid Use Disorder (MOUD) Treatment in Rural Health Care Systems: A Case Example Cook, Christopher

260 S p.
artikel
290 Experimental Approaches to Screen for Efficacy of Novel Psychedelics Smith, Sharon

260 S p.
artikel
291 Explainable Machine Learning Elucidates the Affective, Cognitive, and Social Factors Driving Non-Medicinal Opioid Use in Young Adults Maxwell, Andrea

260 S p.
artikel
292 EXPLORATION OF HIV RISK BEHAVIORS AND ATTITUDES TOWARDS PREP AMONG PEOPLE WHO INJECT DRUGS BY GENDER AND SEXUAL ORIENTATION Bhatraju, Elenore

260 S p.
artikel
293 Exploring Future Research Needs for Pharmaceutical Pain Management Among Black/Hispanic Populations With Opioid Use Disorder and Liver Disease Barnes, Autumn

260 S p.
artikel
294 Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone Sharma, Anjalee

260 S p.
artikel
295 Exploring Substance Use Among LGB Adults Through the National Institutes of Health All of Us Research Program Lippi, Stephen

260 S p.
artikel
296 Exploring the Impact of the COVID-19 Pandemic on MOUD Retention in a Sample of Rural Primary Care Patients Calhoun, Stacy

260 S p.
artikel
297 Exploring the Relationships Between Dimensions of Adverse Childhood Experiences and Cannabis Use Outcomes Lopez-Quintero, Catalina

260 S p.
artikel
298 Extended Access to Fentanyl Self-Administration During Pregnancy: Effects on Dams and Offspring Aldridge, Barrett

260 S p.
artikel
299 Extended Observation of Reduced Methamphetamine Use With Bupropion and Naltrexone Treatment Li, Michael

260 S p.
artikel
300 Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial Levin, Frances

260 S p.
artikel
301 Facilitating Supervised Self-Management of Stimulant Medications Among Adolescents: Improving Adherence, Supporting Caregivers, and Reducing the Risk of Misuse Perse, Artin

260 S p.
artikel
302 Facilitators of and Barriers to Buprenorphine-Naloxone Initiation for People With Opioid Use Disorder in the Emergency Department: A Scoping Review Bozinoff, Nikki

260 S p.
artikel
303 FACTORS ASSOCIATED WITH ACTIVE AMPHETAMINE-TYPE STIMULANT USE AMONG MALAYSIAN TRANSGENDER WOMEN JadKarim, Luzan

260 S p.
artikel
304 Factors Associated With Patient Referral From Rural Primary Care Clinics to Vendor-Based Telemedicine for Opioid Use Disorder Treatment Lin, Chunqing

260 S p.
artikel
305 Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida Cook, Robert

260 S p.
artikel
306 Factors Associated With Self-Reported Cannabis Use Problems Among People With HIV Screened in Primary Care Mian, Maha

260 S p.
artikel
307 Factors Associated With Sleep Health Among Community Recruited People who Inject Drugs in Los Angeles, CA and Denver, CO, 2021-22 Ruth, Avaion

260 S p.
artikel
308 Factors Related to Cannabis Use in Individuals Over 65 Russell, Lauren

260 S p.
artikel
309 Familiarity With Substances and Adolescent Substance Use Bhatia, Devika

260 S p.
artikel
310 Fda Regulation of Cannabis and Cannabis-Derived Compounds Bonson, Katherine

260 S p.
artikel
311 Feasibility and Acceptability of an Ecological Momentary Intervention of Implementation Intentions Delivered by Text Message to Reduce Cigarette Smoking Saunders, Elizabeth

260 S p.
artikel
312 Feasibility and Outcomes of a Community-Pharmacist Led Program to Treat Hepatitis C Virus Among Persons who Inject Drugs Tsui, Judith

260 S p.
artikel
313 Feasibility of Ecological Momentary Assessment With People who Inject Drugs: A Pilot Study Phillips, Kristina

260 S p.
artikel
314 Federal Agencies and Cannabis Research: Updates From NIH, FDA and DEA Gust, Steve

260 S p.
artikel
315 Federal Agencies and Cannabis Research: Updates from NIH, FDA, and DEA Laughery, Katie

260 S p.
artikel
316 Fentanyl Concentrations and Withdrawal in Illicit Fentanyl Exposure Bird, Helen

260 S p.
artikel
317 Fentanyl Route of Administration and Overdose Risk: A Preliminary Analysis of Baseline Data From a Cohort of Overdose Survivors in San Francisco and Boston Coffin, Phillip

260 S p.
artikel
318 Fentanyl Test Strip Knowledge and Attitudes Among Patients in the Emergency Department who Use Drugs Reed, Megan

260 S p.
artikel
319 Fine-Grained Patterns of Combusted Cigarette and E-Cigarette Use Among Dual Users Who Intend to Quit Smoking Wiley, Rhiannon

260 S p.
artikel
320 First in the World Trial of low Intensity Focused Ultrasound for Substance Use Disorder Thompson-Lake, Daisy

260 S p.
artikel
321 FISCHMAN LECTURE: MY 30-YEAR RESEARCH JOURNEY: HIGH-RISK SITUATIONS, COPING SKILLS, AND LESSONS LEARNED ALONG THE WAY Schmitz, Joy

260 S p.
artikel
322 fMRI and Eye-Tracking During Pavlovian Conditioned Approach: Measuring Sign- And Goal-Tracking in Humans Cope, Lora

260 S p.
artikel
323 FMRI INFORMED TMS TARGET SELECTION FOR FRONTOAMYGDALA CIRCUIT IN PEOPLE WITH METHAMPHETAMINE USE DISORDER Soleimani, Ghazaleh

260 S p.
artikel
324 FORUM: RESTRUCTURING THE PATHWAY FROM DISCOVERY TO DISSEMINATION OF NEW MEDICATIONS IN THE ACADEMIC ENVIRONMENT France, Charles

260 S p.
artikel
325 Frequency of Fentanyl Injection is Associated With Hepatitis C Status: A Cross-Sectional Study Bayoumi, Ahmed

260 S p.
artikel
326 GABAPENTIN PRESCRIBING PATTERNS IN PATIENTS TREATED FOR ALCOHOL USE DISORDER Mendelson, John

260 S p.
artikel
327 GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE Ellis, Matthew

260 S p.
artikel
328 Gender Differences in Smoking Dependence Motives Black, Dominique

260 S p.
artikel
329 Gender Differences in Substance Use Treatment Interest Pridgen, Bailey

260 S p.
artikel
330 Gender, Mental Health, and Cannabis Use Amongst Students in the United States During the Pandemic: Results From the COVID-19 Cannabis Health Study Borja, Ana

260 S p.
artikel
331 Geographic Variations in Fentanyl Positive Urine Drug Screens in the United States, 2021 Winstanley, Erin

260 S p.
artikel
332 Governor's Square 15 Quam, Annika

260 S p.
artikel
333 Greater Coupling of Pain Intensity and Opioid Craving After Delaying Methadone Dose Among Veterans With Opioid Use Disorder MacLean, Robert

260 S p.
artikel
334 Greater Ethnic Identity and Lower Perceived Stigmatization Relate to Lower Compulsive Craving Behaviors in Individuals in Recovery From Opioid Use Disorder Davis, Chrysantha

260 S p.
artikel
335 Habitual Use of Tobacco and Alcohol on Tendency of Depression and Anxiety Evidence From 27,942 Taiwan Biobank Participants Chen, Shaw-Ji

260 S p.
artikel
336 Harm Reduction in the Field: First Responders' Perceptions of Opioid Overdose Interventions Fockele, Callan

260 S p.
artikel
337 Health and Social Service Providers’ Perspectives on Peer Distribution of HIV Self-Test Kits With Pre-Exposure Prophylaxis Information Among People who Inject Drugs in San Diego County, California Bazzi, Angela

260 S p.
artikel
338 Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System Busse, Anja

260 S p.
artikel
339 Hepatitis C and HIV Among Substance Users in Mizoram, Northeast India Ralte, Lalchhanhima

260 S p.
artikel
340 Heroin Use, Non-Medical Prescription Opioid Use, and Injection Drug Use Among Urban High School Students Across the US Byregowda, Himani

260 S p.
artikel
341 High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study Vidot, Denise

260 S p.
artikel
342 HIGH SUICIDALITY PREDICTS OVERDOSE EVENTS AMONG PEOPLE WITH SUBSTANCE USE DISORDER: A LATENT CLASS ANALYSIS Schmidt, Renae

260 S p.
artikel
343 High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers Heidari, Omeid

260 S p.
artikel
344 Hippocampal Subfield Volume as a Function of Cannabis Use and Cannabis Use Disorder Guerin, Alexandre

260 S p.
artikel
345 Historical Trauma, Racial Identity, and Binge Drinking Among Black Young Adults Ebrahimi, Chantel

260 S p.
artikel
346 History of Traumatic Events and Opioid Use Among Justice Involved Mothers Staton, Michele

260 S p.
artikel
347 HIV and Hepatitis C Virus-Related Misinformation Remains a Challenge to Improved Clinical Outcomes Among Persons who use Drugs During the U.S. Opioid Overdose Crisis Gomez, Alejandro De La Hoz

260 S p.
artikel
348 HIV Pre-Exposure Prophylaxis Awareness, Use, Willingness, and Physician Engagement Across Sexually and Gender Diverse Veterans who Use Drugs Gross, Ariana

260 S p.
artikel
349 HIV PRE-EXPOSURE PROPHYLAXIS PROGRAMMATIC PREFERENCES AMONG PEOPLE WHO INJECT DRUGS: A DISCRETE CHOICE EXPERIMENT Eger, William

260 S p.
artikel
350 HIV Prevention Intervention Delivery via Facebook With Rural Appalachian Women who Use Drugs: Risk-Related Outcomes During Community Re-Entry Following Incarceration Dickson, Megan

260 S p.
artikel
351 Hopelessness and Impulsivity and Recent Non-Fatal Overdose Among Overdose Survivors who Actively Use Nonprescribed Opioids in San Francisco and Boston McMahan, Vanessa

260 S p.
artikel
352 How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine Daniulaityte, Raminta

260 S p.
artikel
353 How did the Removal of IQOS® Tobacco Heating System (THS) From the Market Impact Tobacco Harm Reduction? Noggle, Brendan

260 S p.
artikel
354 Hub Disruption in HIV Disease and Cocaine Use Disorder Al-Khalil, Kareem

260 S p.
artikel
355 HUMAN FORUM: NOTHING ABOUT US WITHOUT US: ENGAGING INDIVIDUALS WITH LIVED EXPERIENCE OF SUBSTANCE USE DISORDERS IN SUBSTANCE USE RESEARCH DEVELOPMENT AND IMPLEMENTATION Alshaarawy, Omayma

260 S p.
artikel
356 Hyperarousal/Sleep Disturbance and Inability to Discontinue Chronic Hypnotic Use Roehrs, Timothy

260 S p.
artikel
357 I Crave Not to Feel Uncomfortable: Craving for Opioids and Cannabis Among Patients With Chronic Pain Thrul, Johannes

260 S p.
artikel
358 IDENTIFICATION AND CHARACTERIZATION OF CANNABIS PRODUCTS ON THE DARK WEB Nali, Matthew

260 S p.
artikel
359 IDENTIFICATION AND CHARACTERIZATION OF UNREGULATED MARKETING AND SALE OF CANNABIS PRODUCTS ON THE MESSAGING SERVICE PLATFORM TELEGRAM Mackey, Timothy

260 S p.
artikel
360 IDENTIFICATION OF A FENTANYL-TARGETING MONOCLONAL ANTI CSX-1004 THAT BLOCKS FENTANYL’S EFFECTS IN SQUIRREL MONKEYS Desai, Rajeev

260 S p.
artikel
361 Identification of Epigenetic Biomarkers Associated With Prenatal Exposure to Substances of Abuse Baldwin, Aileen

260 S p.
artikel
362 Identifying Brief Intervention Factors to Improve Cannabis Related Outcomes in Adolescents and Emerging Adults: A Systematic Review Gex, Kathryn

260 S p.
artikel
363 Identifying Common Drug Abuse Products in Polysubstance and Serious Adverse Events Bernander, Paula

260 S p.
artikel
364 Identifying Implementation Strategies to Inform Implementation of a Hospital-Based Opioid Use Disorder (OUD) Treatment Intervention Across Twelve Hospitals in Colorado Mikulich-Gilbertson, Susan

260 S p.
artikel
365 IDENTIFYING LATENT CLASSES OF EMERGENCY DEPARTMENT PATIENTS RECEIVING TELEHEALTH PEER RECOVERY COACH SERVICES FOR SUBSTANCE USE DISORDER AND ASSESSING CLASS PREDICTORS AND OUTCOMES Watson, Dennis

260 S p.
artikel
366 Identifying Neurocognitive Mechanisms Underlying the Effects of Structural Racism on Risk for Substance Misuse Using the ABCD Study Johnson, Micah

260 S p.
artikel
367 IDENTIFYING STRUCTURAL RISK FACTORS FOR OVERDOSE FOLLOWING INCARCERATION: A CONCEPT MAPPING STUDY Nall, Samantha

260 S p.
artikel
368 IDENTIFYING THE NEED FOR BRIEF POLYDRUG USE INTERVENTIONS AMONG BLACK AND HISPANIC SEXUAL MINORITY MEN IN THE U.S. Moody, Raymond

260 S p.
artikel
369 Identifying Vape-Related Content on TikTok Using Automatic Clustering Kong, Grace

260 S p.
artikel
370 Illicit Drug Use in Adolescents Versus Adults Among Those With Use of Other Psychoactive Substance or Depressive Symptoms: A Conditional Prevalence Analysis of the 2014 and 2018 National Survey of Substance Use in Taiwan Wu, Shang-Chi

260 S p.
artikel
371 Impact of a Brief Educational Intervention on Preferences for Medications for Opioid Use Disorder Lagisetty, Pooja

260 S p.
artikel
372 Impact of an Addiction Consultation Team on the Initiation of Medication for Opioid Use Disorder and Readmissions for Patients With Substance Use Disorders Kehne, Adrianne

260 S p.
artikel
373 Impact of an Opioid Use Disorder Treatment Implementation Intervention Among Patients With and Without Co-Occurring Substance Use Disorders in the Veterans Health Administration Frost, Madeline

260 S p.
artikel
374 Impact of Cannabidiol on Reward- And Stress-Related Neurocognitive Processes Among Individuals with Opioid Use Disorder: A Pilot, Double-Blind, Placebo-Controlled, Cross-Over Trial Suzuki, Joji

260 S p.
artikel
375 IMPACT OF IMPAIRED COGNITIVE FUNCTIONING AMONG PERSONS ON MEDICATION FOR OPIOID USE DISORDER Mistler, Colleen

260 S p.
artikel
376 Impact of Medication-Based Treatment on Healthcare Utilization Among Individuals With Opioid Use Disorder: A Secondary Analysis of the X:BOT Clinical Trial Gopaldas, Manesh

260 S p.
artikel
377 Impact of Methamphetamine Use on Cardiovascular Risk and Deprivation: Objective Assessment Using Wearable Activity Tracker and Mobile Application Takano, Ayumi

260 S p.
artikel
378 Impact of Oat Initiation During Acute Hospitalization on Readmission, Overdose, and Mortality Among People With Opioid Use Disorder Mihic, Tamara

260 S p.
artikel
379 Implementation Facilitation Improves Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine in Four Urban Academic Centers Hawk, Kathryn

260 S p.
artikel
380 Implementation of a “Tele-Peer” Model to Expand Access to Medications for Opioid Use Disorder (MOUD) in a Rural Emergency Department (R-ED) in South Carolina Gainey, Sarah

260 S p.
artikel
381 Implementation of Virtual Contingency Management Within a Statewide Opioid Treatment Program Provider Network in Texas Bolton, Carma Deem

260 S p.
artikel
382 Implementing a Patient-Centered, Rapid-Access Substance Use Treatment Program in Primary Care Jeansonne, Scott

260 S p.
artikel
383 Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment Regnier, Sean

260 S p.
artikel
384 Incidence of Opioid Misuse by Cigarette Smoking Status in the United States Parker, Maria

260 S p.
artikel
385 Inclusion of Community Members in Initial Design Stages of Technology-Based Interventions Addressing Topics Including Substance Use and HIV: A Systematic Review Ardouin-Guerrier, Mary-Andrée

260 S p.
artikel
386 Increased Risk of Mortality From Polysubstance Use Among Hospitalized Patients With Opioid Use Disorder Hochstatter, Karli

260 S p.
artikel
387 Increasing Capacity of International Researchers and Universities Through Collaboration Searcy, Carly

260 S p.
artikel
388 Increasing Risk of Cannabis Use Disorder Among U.S. Veterans With Chronic Pain: 2005-2019 Mannes, Zachary

260 S p.
artikel
389 Incubation of Oxycodone Craving After Voluntary Abstinence is Associated With Increased Activity of Claustrum and Paraventricular Nucleus of Thalamus (PVT) Projections to Ventral Subiculum Batista, Ashley

260 S p.
artikel
390 Individuals With Cannabis Use Disorder Display Altered Parasympathetic HRV During Waking and Sleeping Hours Relative to Light Cannabis Users Pearlman, Morgan

260 S p.
artikel
391 INDIVIDUALS WITH SUBSTANCE USE DISORDER EXHIBIT HEIGHTENED ANXIETY AND ANTERIOR CINGULATE ACTIVATION DURING FEAR CONDITIONING Pleiman, Abigail

260 S p.
artikel
392 INFLUENCE OF 5HT1B ACTIVATION ON THE REINFORCING EFFECTS OF INTRAVENOUS COCAINE Stoops, William

260 S p.
artikel
393 Initial Results of the First Momentary-Assessment Study of U.S. Adults who Use Kratom Smith, Kirsten

260 S p.
artikel
394 Initial Validation and Characterization of a Measure to Assess Attitudes Toward Medications for Opioid Use Disorder for Outpatient Populations Bushey, Michael

260 S p.
artikel
395 Initiation and Retention in Medications for Opioid Use Disorder (MOUD) Among Women: A Multi-Paneled Qualitative Study of Women in Recovery, Women who Terminated Treatment, and the Professionals who Serve Them Apsley, Hannah

260 S p.
artikel
396 Initiations of Safer Supply Hydromorphone Increased During the COVID-19 Pandemic in Ontario: An Interrupted Time-Series Analysis Young, Samantha

260 S p.
artikel
397 IN MEMORIAM MARY JEANNE KREEK Butelman, Eduardo

260 S p.
artikel
398 Innovations in Small Business Telehealth Technologies for Opioid Use Disorder: Automated Assessments, Electronic Health Record integrations, and Medication Shipping Jimes, Cynthia

260 S p.
artikel
399 INNOVATOR SYMPOSIUM: MEDICATION DEVELOPMENT FOR METHAMPHETAMINE USE DISORDER Dwoskin, Linda

260 S p.
artikel
400 INTERACTION OF CIGARETTE NICOTINE DOSE AND DOSE EXPECTANCY IN HEALTH PERCEPTIONS AND BEHAVIORAL ECONOMIC DEMAND Gelino, Brett

260 S p.
artikel
401 Intersectional Stigma and Aging Among Older Adults With Opioid Use Disorder Han, Benjamin

260 S p.
artikel
402 Intranasal Human Abuse Potential of PF614: A Novel ‘Next Generation’ Trypsin Activated Abuse Protected (TAAP) Opioid Schmidt, William K.

260 S p.
artikel
403 Introducing a Socio-Ecological Model of Collegiate Recovery Programs Vest, Noel

260 S p.
artikel
404 Investigating Sex Differences in the Relations Between Parent/Guardian Promotion of Tobacco Abstinence, and Tobacco Use in a Nationally Representative Sample of Black Adolescents Alexander, Wynta

260 S p.
artikel
405 Investigating the Association Between Discrimination, Internalizing Symptoms, and Alcohol Use Among Latino/a Immigrant Parent in the United States Macias, Miracle

260 S p.
artikel
406 Investigating the Simultaneous Effects of Cannabidiol Isolate and Caffeine Ferretti, Morgan

260 S p.
artikel
407 Investigation of Life Events Associated With Development of OUD in Young Adults: A Longitudinal Study of a High-Risk Clinical Population Blake, Grace

260 S p.
artikel
408 Involvement of 5-HT2A and 5-HT1A Receptors in the Pharmacological Effects of 5-MeO-DMT Analogs in Male C57BL/6J Mice Glatfelter, Grant

260 S p.
artikel
409 Is Abstinence From Alcohol and Smoking Associated With Better Mood Among People With HIV? Freibott, Christina

260 S p.
artikel
410 Is Drowsiness After Cannabis Use Predictive of Magnitude of Driving Impairment Brown, Timothy

260 S p.
artikel
411 Is Resilience Enough? Resilience Processes to Intersectional Stigma Among People who Inject Drugs (PWID) in Appalachia Ohio Lancaster, Kathryn

260 S p.
artikel
412 Is the Whole Greater Than the Sum of Its Parts? Examining How Dosage of Intervention Components From the Sacramento Neighborhood Alcohol Prevention Project Affect Child Abuse and Neglect Freisthler, Bridget

260 S p.
artikel
413 It’s Just, Like, a Younger Guy Thing to Smoke Weed: Gendered Cannabis Norm Perceptions Among Treatment-Seeking Adults Matheson, Justin

260 S p.
artikel
414 JAIL-BASED MEDICATION FOR OPIOID USE DISORDER AND PATTERNS OF COMMUNITY RE-ENTRY AFTER RELEASE: A SEQUENCE ANALYSIS McDonald, Ryan

260 S p.
artikel
415 Justice Community Opioid Innovations Network Linkage Facilitation Stein, Lynda

260 S p.
artikel
416 Known Fentanyl Use and Potential Reasons for Non-Use of Fentanyl Test Strips Among People who Use Drugs Aronson, Ian

260 S p.
artikel
417 Kratom Use and Adverse Events: Findings From the NDEWS Rapid Street Reporting Study Striley, Catherine

260 S p.
artikel
418 Latent Class Analysis of Psychosocial Factors Among People Living with HIV who Use Substances Feaster, Daniel

260 S p.
artikel
419 Latinx Combustible Cigarette Smokers Versus Dual Users: Differences in Alcohol and Drug Use Problem Severity Shepherd, Justin

260 S p.
artikel
420 LATINX INDIVIDUALS WHO SMOKE DAILY WITH AND WITHOUT A PROBABLE ANXIETY DISORDER: DIFFERENCES IN SMOKING BEHAVIOR AND BELIEFS ABOUT ABSTINENCE Clausen, Bryce

260 S p.
artikel
421 Life Still Exists: Describing the HIV Risk Environment for Women who Inject Drugs-Living With HIV in Kenya Lyons, Myla

260 S p.
artikel
422 Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008–2019 Gorfinkel, Lauren

260 S p.
artikel
423 Likelihood and Duration of Breastfeeding by Maternal Smoking and Drinking Change During Pregnancy Washio, Yukiko

260 S p.
artikel
424 Lived Experiences of Addiction Counselors: A Protocol Exploring Stigma in a Time of Regulatory Change Within Opioid Treatment Programs Eggert, Kathryn

260 S p.
artikel
425 Long-Term Mortality After Drug Use-Associated Endocarditis is High and Differs by Race and Sex: Results of a Statewide Study Schranz, Asher

260 S p.
artikel
426 Long-Term Relationship Between Opioid Use and Change in HIV Disease Severity: A Prospective Cohort Study Bhondoekhan, Fiona

260 S p.
artikel
427 LOSS AVERSION PREDICTS CIGARETTE SMOKING STATUS ACROSS GENDER AND SOCIOECONOMIC LEVELS Thrailkill, Eric

260 S p.
artikel
428 Marijuana Use Among Asian American Adolescents: An Analysis of Specific Ethnic Groups Luo, Ting

260 S p.
artikel
429 Material Hardship and Encampment Relocation Among Unhoused People who Use Drugs: Confirmatory Factor Analysis and Structural Equation Modeling of a Scale Measure Goldshear, Jesse

260 S p.
artikel
430 Measuring Cannabis Reinforcement Among Young Adults: A Mixed Methods Examination Gebru, Neo

260 S p.
artikel
431 MEDIA FORUM Kleykamp, Bethea

260 S p.
artikel
432 Mediation Effect of the Alcohol Reinforcement Value on the Association Between Poor Sleep Quality and Problematic Drinking Among Adolescents Sancho-Domingo, Clara

260 S p.
artikel
433 MINI-SYMPOSIUM: BEYOND THE DICHOTOMY Struble, Cara

260 S p.
artikel
434 MINI-SYMPOSIUM: FROM INITIATION TO ADDICTION: A MEASURE OF THE FULL RANGE OF INVOLVEMENT FOR OPIOIDS, CANNABIS, AND ALCOHOL Ridenour, Ty

260 S p.
artikel
435 MINI-SYMPOSIUM: HARM REDUCTION UTILIZATION AND STRATEGIES Pho, Mai

260 S p.
artikel
436 MINI-SYMPOSIUM: MONITORING AND DIAGNOSTIC DEVICES FOR SUBSTANCE USE DISORDERS: CHALLENGES AND OPPORTUNITIES Gutowski, Stacie

260 S p.
artikel
437 MINI-SYMPOSIUM: 2022 NIDA CRAVING CHALLENGE Andrew James, G.

260 S p.
artikel
438 Mobile EEG Correlates of Frequent Cannabis Use are Sex- and Age-Dependent Murray, Conor

260 S p.
artikel
439 Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I Feasibility, Usability, and Efficacy Randomized Clinical Trial McPherson, Sterling

260 S p.
artikel
440 Mobile Units Improve Access to Medications for Opioid Use Disorder: A Qualitative Implementation Study Chatterjee, Avik

260 S p.
artikel
441 MODELING APPROACH Lee, Juhan

260 S p.
artikel
442 Modeling Common and Patient-Specific Resting-State Connectivity to Predict Craving and Smoking Cessation Treatment Response Murray, Laura

260 S p.
artikel
443 Moderate-Vigorous Physical Activity and Opioid Use Status Lee, Elizabeth

260 S p.
artikel
444 Modes of Marijuana Use by Secondary School Students in 2019–20, Findings From a California Statewide Survey Wang, Jijiang

260 S p.
artikel
445 Modular-Level Alterations in Functional Brain Connectivity Associated With Cannabis Use Meade, Christina

260 S p.
artikel
446 Modulation of Estradiol Signaling in the Amygdala Impacts Heroin Extinction Memory Recall in a Sex-Specific Manner Carter, Jordan

260 S p.
artikel
447 Molecular Signaling Pathways in the Hippocampus of Rhesus Monkeys With Chronic Alcohol Use Pareek, Tanya

260 S p.
artikel
448 Momentary Latent Class Membership to Predict Self-Efficacy and Subsequent Substance Use Wang, Danny

260 S p.
artikel
449 MONITORING ONLINE ILLICIT DRUG MARKET DURING THE COVID-19 Otiashvili, David

260 S p.
artikel
450 More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment Dewey, Jodie

260 S p.
artikel
451 Motivation and Context of Concurrent Stimulant and Opioid Use Among Persons who Use Drugs in the Rural United States: A Multi-Site Qualitative Inquiry Fredericksen, Rob

260 S p.
artikel
452 Motivation to Seek Mental Health Services Young Black Men Bazan, Carolyn

260 S p.
artikel
453 Motives and Experiences of Psychedelic and Cannabis Co-Use Among Emerging Adult Cannabis Users: A Qualitative Analysis Conn, Bridgid

260 S p.
artikel
454 Motives Behind Frequency of Cannabis Use: A Comparison of Regular and Occasional Young Adult Cannabis Users Li, Anna

260 S p.
artikel
455 Naloxone Distribution in the Emergency Department: Program Evaluation of the University of Washington Harborview Medical Center Emergency Department’s Response to Washington State Bill 5195 Morse, Sophie

260 S p.
artikel
456 Naloxone Expansion is Not Associated With Increases in Adolescent Heroin Use and Injection Drug Use: Evidence From 44 U.S. States Bruzelius, Emilie

260 S p.
artikel
457 NALOXONE IS LESS EFFECTIVE AT REVERSING THE PHYSIOLOGICAL EFFECTS OF FENTANYL-METHAMPHETAMINE MIXTURES THAN FENTANYL ALONE Seaman, Robert

260 S p.
artikel
458 Naloxone Usage Over Time as Reported to the National Poison Data System (NPDS) Fox, Evelyn

260 S p.
artikel
459 NATIONAL TRENDS IN METHAMPHETAMINE-RELATED PSYCHIATRIC HOSPITALIZATIONS IN THE UNITED STATES, 2015-2019 Swathi, Pallavi Aytha

260 S p.
artikel
460 Neighborhood and Individual Disparities in Community-Based Naloxone Access Nesoff, Elizabeth

260 S p.
artikel
461 Neural and Behavioral Habituation to Sad Infant Stimuli in Mothers who Use Substances McCurdy, Li Yan

260 S p.
artikel
462 Neural and Longitudinal Mechanisms Mediating Drug-Related Optimism Bias in Opioid Addiction Alvarez, Emmanuel

260 S p.
artikel
463 NEURAL CIRCUITRY IN OBJECT RECOGNITION MEMORY AND METHAMPHETAMINE ADDICTION Goldsmith, Sarah

260 S p.
artikel
464 Neural Correlates of Controllable Negative Life Events and Their Relationships With Cannabis and Alcohol Use Initiation Zhao, Yihong

260 S p.
artikel
465 Neural Reward Reactivity to Delta-9-Tetrahydrocannabinol (THC) Among Young Adults as a Function of Lifetime Cannabis Use Frequency Brooks, Julia

260 S p.
artikel
466 NEUROCHEMICAL CHANGES IN GLUTAMATE AND GABA AND COGNITIVE FUNCTION IN COCAINE DEPENDENT INDIVIDUALS DURING EARLY WITHDRAWAL Das, Namrata

260 S p.
artikel
467 Neurofunction and Insomnia Symptoms Among Women in Treatment for Opioid Use Disorder White, Augustus

260 S p.
artikel
468 NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism Koob, George

260 S p.
artikel
469 Nicotine Self-Administration Differentially Modulates Ventral Tegmental and Medial Habenular Neuronal Excitability Olszewski, Nathan

260 S p.
artikel
470 Nicotine Use and Metabotropic Glutamate Receptor 5 (mGluR5) in Individuals With Major Depressive and Post Traumatic Stress Disorders Baldassarri, Stephen

260 S p.
artikel
471 NIDA EARLY CAREER WORKSHOP Friend, Lindsey

260 S p.
artikel
472 NIDA-Funded Small Business Companies Successfully Contribute to NIH Heal Initiative Wang, Jia Bei

260 S p.
artikel
473 NIDA UPDATE Volkow, Nora

260 S p.
artikel
474 NMRA-140, a Novel and Selective Kappa Opioid Receptor Antagonist: Mode of Action Profiling Studies Demonstrate No Opioid Agonist Properties Implicated in Opioid-Related Abuse Morrison, Filomene

260 S p.
artikel
475 Nomi™ SMRxT Bottles Track Daily Medication Intake Patterns in Chronic Pain Patients Prescribed Opioids Merritt, Christina

260 S p.
artikel
476 Nondrug Reward and Recovery From Addiction: Socio-Spatial Contexts, Interindividual Heterogeneity, and Change Over Time Stull, Samuel

260 S p.
artikel
477 Non-Fatal Drug Overdose Among Persons who Inject Drugs During First Two Years of the COVID-19 Pandemic in New York City: Prevalence, Risk Feelemyer, Jonathan

260 S p.
artikel
478 Novel ‘Agnostic’ Pharmacologic Approach to Polysubstance Overdose Miller, Thomas

260 S p.
artikel
479 Novel Maintenance Therapeutic for Opioid Use Disorder Gehlert, Don

260 S p.
artikel
480 Novel Neurotheranostic for MR Imaging of Dopamine Transporters (DAT) and Treatment of Dopaminergic Neurodegeneration in Methamphetamine Use Disorder (MUD) Vitaliano, Gordana

260 S p.
artikel
481 OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM Acheson, Liam

260 S p.
artikel
482 Open Board
260 S p.
artikel
483 Open Board
260 S p.
artikel
484 Open Board
260 S p.
artikel
485 Open Board
260 S p.
artikel
486 Open Board
260 S p.
artikel
487 Open Board
260 S p.
artikel
488 Open Board
260 S p.
artikel
489 Open Board
260 S p.
artikel
490 Open Board
260 S p.
artikel
491 Open Board
260 S p.
artikel
492 Open Board
260 S p.
artikel
493 Open Board
260 S p.
artikel
494 Open Board
260 S p.
artikel
495 Open Board
260 S p.
artikel
496 Open Board
260 S p.
artikel
497 Open Board
260 S p.
artikel
498 Open Board
260 S p.
artikel
499 Open Board
260 S p.
artikel
500 Open Board
260 S p.
artikel
501 Open Board
260 S p.
artikel
502 OpiAID: A Data Driven Approach to Treating Opioid Dependence Evonko, Christopher

260 S p.
artikel
503 Opioid Agonist Treatment Modifications During COVID‐19 Pandemic Sproule, Beth

260 S p.
artikel
504 Opioid and Stimulant-Attributed Treatment Admissions and Fatal Overdoses Among Women: Using National Surveillance Data to Examine Racial/Ethnic Differences, 1992-2020 Jones, Abenaa

260 S p.
artikel
505 OPIOID- AND STIMULANT-INVOLVED OVERDOSE DEATHS AMONG BLACK PEOPLE IN ST. LOUIS, MO: EXAMINING SOCIAL DETERMINANTS OF HEALTH Brown, Kanila

260 S p.
artikel
506 OPIOID DEMAND AND PAIN-RELATED MEASURES FOLLOWING TRAUMA SURGERY Yoon, Jin

260 S p.
artikel
507 Opioid Prescribing Trajectories in Veterans With and Without Substance Use Disorder Black, Anne

260 S p.
artikel
508 Opioid-Related Poisoning in Kentucky Medicaid Beneficiaries Receiving Buprenorphine, Methadone or Naltrexone Hammerslag, Lindsey

260 S p.
artikel
509 Opioid Use and Treatment Retention Outcomes Among Patients Initiating Methadone Versus Buprenorphine Treatment in Rural Practices Khairy, Lisa

260 S p.
artikel
510 Opioid Use Disorder Treatment in Medicaid Managed Care Plans Myers, Amanda

260 S p.
artikel
511 Opioid Withdrawal Symptoms and Reasons for Discontinuation of Low-Dose Buprenorphine Induction for Treatment of Opioid Use Disorder in Hospitalized Patients Chen, Catherine

260 S p.
artikel
512 Opposing Genetic Influences on Opioid Overdose and Self-Administration in Rats Grasing, Ken

260 S p.
artikel
513 Optimizing Recovery Funding: A National Look at Strategies for State Funding of Recovery Support Services for Substance Use Disorders Murphy, Zoe

260 S p.
artikel
514 Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery Spitz, Stephanie

260 S p.
artikel
515 Optimizing the Training Conditions of Rats in Nicotine Drug Discrimination Studies Kusi-Boadum, Nana Kofi

260 S p.
artikel
516 ORGANIC CATION TRANSPORTER 3 (OCT3) IS CRUCIAL FOR THE REINFORCING EFFECTS OF AMPHETAMINE Mason, Briana

260 S p.
artikel
517 Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City Scheidell, Joy

260 S p.
artikel
518 Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study Banta-Green, Caleb

260 S p.
artikel
519 Pain Catastrophizing Moderates the Relationship Between Chronic Pain and Insomnia Severity in Persons With Opioid Use Disorder Baime, Melanie

260 S p.
artikel
520 Pain in Opioid Use Disorder Recovery: Is Pain Severity or Chronicity a Stronger Predictor of Health Outcomes? Craft, William

260 S p.
artikel
521 Pandemic Era Changes in Drug Use and Harm Reduction Behavior Among People who Use Drugs in Rural Illinois Rains, Alex

260 S p.
artikel
522 Parent Influence and Alcohol Use by Youth With Chronic Medical Conditions Calihan, Jessica

260 S p.
artikel
523 PARTICIPANT RETENTION IN DIGITALLY-PROVIDED BUPRENORPHINE TREATMENT FOR OPIOID USE DISORDER COMPARED WITH TREATMENT AS USUAL OFFICE-BASED TREATMENT: AN OBSERVATIONAL LONGITUDINAL COHORT STUDY Chan, Brian

260 S p.
artikel
524 Patient Characteristics Associated With Retention on XR-NTX in the CTN-0051 Trial Opara, Onumara

260 S p.
artikel
525 Patient Characteristics of Fentanyl Positive Individuals With Opioid Use Disorder Greiner, Miranda

260 S p.
artikel
526 Patient Experiences With Buprenorphine Following Discontinuation of Long-Term Opioid Therapy Wyse, Jessica

260 S p.
artikel
527 Patient Navigation for Pregnant Persons With Opioid Use Disorder: Results of a Multisite Pilot Study Cochran, Gerald

260 S p.
artikel
528 Patient Navigation Promotes Substance Use Disorder Treatment Retention Among Hospital Patients Experiencing Homelessness Nordeck, Courtney

260 S p.
artikel
529 Patient Perspectives on an Open Access Model for Methadone Treatment: A Research and Process Improvement Protocol Madden, Lynn

260 S p.
artikel
530 Patient Reported Insights to Guide Development and Implementation of Sleep Interventions in the Opioid Use Disorder Treatment Setting Eglovitch, Michelle

260 S p.
artikel
531 Patterns and Clinical Correlates of Depressive Symptoms, Pain Impact, and Sleep Disturbance Among Patients in Residential Substance Use Treatment Ellis, Jennifer

260 S p.
artikel
532 Peer Intervention to Link Overdose Survivors to Treatment (PILOT): Study Protocol of a Multi-Site, Randomized Controlled Trial in the National Institute on Drug Abuse Clinical Trials Network Papa, Carrie

260 S p.
artikel
533 Peer Recovery Center of Excellence Needs Assessment of Minority AIDS Initiative Grantees' Peer Worker Training Needs Teti, Michelle

260 S p.
artikel
534 Peer Support for Individuals Presenting in Emergency Departments Following Opioid Overdose: Association of Program Implementation With Drug Treatment Initiation and Repeat Overdose Treitler, Peter

260 S p.
artikel
535 Perceived Importance of Counseling Among Patients Receiving Methadone Treatment Beitel, Mark

260 S p.
artikel
536 Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy Perez-Pedrogo, Coralee

260 S p.
artikel
537 Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder Gicquelais, Rachel

260 S p.
artikel
538 Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids Malone, Natalie

260 S p.
artikel
539 Perceptions of Syndromic Surveillance to Prevent Overdose in Lowell, Massachusetts: Qualitative Perspectives of Community Leaders and People who Use Drugs Cyr, Kevin

260 S p.
artikel
540 Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder Williams, Emily

260 S p.
artikel
541 Persistent Anxiety is Associated With Reporting At-Risk Drinking During COVID-19 Among Women in a Community Setting Berger, Alyssa

260 S p.
artikel
542 PET Imaging of Kappa Opioid Receptors in Socially Housed Female and Male Monkeys: Effects of Chronic Cocaine Self-Administration Johnson, Bernard

260 S p.
artikel
543 PHARMACOLOGICAL EFFECTS OF 2-BENZYLBENZIMIDAZOLE OPIOIDS EMERGING IN CLANDESTINE DRUG MARKETS WORLDWIDE Baumann, Michael

260 S p.
artikel
544 Pharmacological Manipulation of Temporal Brain State Dynamics During Rest Hill, Justine

260 S p.
artikel
545 Pharmacy-Level Barriers to Buprenorphine Dispensing: Evidence From the Medicaid Distributed Research Network in Five States Freeman, Patricia

260 S p.
artikel
546 Photovoice – a Methodology to Engage People With Lived Experience in Order to Understand Contextual Drivers of the Opioid Epidemic and Promote Community Activism Balvanz, Peter

260 S p.
artikel
547 PHOTOVOICE AS A PRISMATIC LENS ON DEFINITIONS OF COMMUNITY AND THEIR IMPLICATIONS FOR STIGMA AND POWER RELATIONS IN ADDRESSING THE OPIOID EPIDEMIC McGladrey, Margaret

260 S p.
artikel
548 Physical Dependence-Like Effects of Acute Benzodiazepine Treatment in Rhesus Monkeys Moreira, Eliseu

260 S p.
artikel
549 Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats McGriff, Shelby

260 S p.
artikel
550 Phytochemical Composition of Fresh Kratom Leaves Collected in the Northern Region of Malaysia Karunakaran, Thiruventhan

260 S p.
artikel
551 Pilot Trial of a Behavioral Economic Intervention to Promote Cannabis-Free Activities for Non-Treatment Seeking Adults With Cannabis Use Disorder Coughlin, Lara

260 S p.
artikel
552 PIPES AND LINES: THE ASSOCIATION OF HARSH SCHOOL PUNISHMENT AND CURRENT SUBSTANCE USE AMONG UNDERREPRESENTED MINORITY JUSTICE-INVOLVED ADOLESCENTS Suarez, James-Angelo

260 S p.
artikel
553 Place Conditioning With Δ9-THC Following Chronic Δ9-THC Exposure During Adolescence Withey, Sarah

260 S p.
artikel
554 Policies Relevant to the Healing Communities Study Kentucky Site Implementation Silwal, Anita

260 S p.
artikel
555 POLICY FORUM Comer, Sandra

260 S p.
artikel
556 Polygenic Risk for Alcohol, Cannabis, and Opioid Use Disorder as Predictors of Age of Initiation in a Community Sample Sosnowski, David

260 S p.
artikel
557 Poly-Substance Use Characterization in an Urban Cohort of Substance Users in Philadelphia, PA Azzoni, Livio

260 S p.
artikel
558 Polysubstance-Use Trends in a Large Urine Drug Testing (UDT) Database: A Latent Class Analysis Bolin, Barrett

260 S p.
artikel
559 Positive Association Between Self-Reported Autonomic Symptoms and Hazardous Cannabis Use Scores in a Community-Based Sample of Adults Keen, Larry

260 S p.
artikel
560 Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communities Kenefick, Leslie

260 S p.
artikel
561 POSITIVE SEROTONIN 5–HT2A/2C RECEPTOR ALLOSTERIC MODULATORS DERIVED FROM OLEAMIDE COMPOUNDS Zamora, Joshua

260 S p.
artikel
562 Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women Preston, Thomas

260 S p.
artikel
563 Preclinical Evidence Supporting the Repurposing of Suvorexant (Belsomra™) to Manage Sleep Disturbances During Initial Cocaine Abstinence Gyawali, Utsav

260 S p.
artikel
564 PREDICTION OF LIFETIME HEROIN OVERDOSE: INJECTION USE, QUIT ATTEMPTS, SUICIDAL IDEATION, AND HEPATITIS Greenwald, Mark

260 S p.
artikel
565 Predictive Relationship Between Different Timescales of Opioid Craving and Opioid Use Grunevski, Sergej

260 S p.
artikel
566 Predictors and Correlates of Hepatitis C Incidence Among Young People who Inject Drugs in the Chicago Metropolitan Area Mackesy-Amiti, Mary

260 S p.
artikel
567 Predictors of Study Treatment Attendance Among Individuals With Opioid Use Disorder Reporting Perceived Social Isolation Ashrafioun, Lisham

260 S p.
artikel
568 Predictors of Treatment Drop-Out and Termination Among Those With Opioid Use Disorder Weaver, Nicholas

260 S p.
artikel
569 Preference for Waterpipes Among Female Patrons of Open-Air Bars in Lagos, Nigeria Onigbogi, Olanrewaju

260 S p.
artikel
570 Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use Meadows, Diamond

260 S p.
artikel
571 Pregnancy and Childbirth in Relation to Receiving the Deferred Prosecution for Amphetamine-Type Substance-Involved Female Offenders in Taiwan Chen, Chuan-Yu

260 S p.
artikel
572 Preliminary Effectiveness of Remote Opioid Overdose and Naloxone Administration Training and Impact of Naloxone Possession on Opioid Use Cropsey, Karen

260 S p.
artikel
573 Preliminary Evidence for Altered Sleep Patterns in Cannabis Users Brown, Tracy

260 S p.
artikel
574 Preliminary Evidence of Heterogeneity in the Opioid Withdrawal Syndrome Martinez, Suky

260 S p.
artikel
575 Preliminary Evidence of Lower Kappa Opioid Receptor Availability in Opiate Use Disorder: An Exploratory 11C-EKAP Positron Emission Tomography Study in Humans Oliva, Henrique

260 S p.
artikel
576 Preliminary Evidence That Individuals With Remitted Alcohol Use Disorder and Major Depressive Disorder Exhibit Enhanced Neural Responses to Reward: An EEG Study Crane, Natania

260 S p.
artikel
577 PrEP and PEP Experience and Willingness in People who Use Opioids: A NIDA Clinical Trials Network Study in Southern U.S. Cities Where HIV Incidence Is High Hatch, Mary

260 S p.
artikel
578 Preparing Recovery Coaches to Discuss Medication for Opioid Use Disorder (MOUD): An Interactive Training and Competency Moffitt, Trevor

260 S p.
artikel
579 Preparing the Addiction Workforce to Practice Informed Eclecticism Through Integration of Motivational Interviewing and Cognitive-Behavioral Therapy Hartzler, Bryan

260 S p.
artikel
580 Prep Experience and Willingness in Substance-Using MSM in Higher Incidence Southern U.S. Cities: NIDA Clinical Trials Network Study Hatch, Mary

260 S p.
artikel
581 Prescribed Opioids and Neurocognitive Status Among Elderly American Indians: Data From the Strong Heart Study Ross, Che

260 S p.
artikel
582 Prescription Amphetamines in People With Opioid Use Disorder and Co-Occurring Psychostimulant Use Disorder Initiating Buprenorphine: An Analysis of Treatment Retention and Overdose Risk Tardelli, Vitor

260 S p.
artikel
583 Prescription Opioid Dose Reductions and Potential Adverse Events: A Multi-Site Study in Eight U.S. Health Systems Metz, Verena

260 S p.
artikel
584 Prescription Opioid Tapering Patterns Prior to Discontinuation of Long-Term, High-Dosage Treatment Episodes Among Adult Medicaid Enrollees Samples, Hillary

260 S p.
artikel
585 Prescription Psychostimulant Use in Pregnant People With Opioid Use Disorder: An Analysis of Buprenorphine Retention and Acute Substance Use Disorder-Related Events Xu, Kevin

260 S p.
artikel
586 PRESERVED NEURAL ENCODING OF SUBJECTIVE VALUATION UNDER UNCERTAINTY IN HUMAN OPIOID ADDICTION LoFaro, Francesca

260 S p.
artikel
587 PREVALENCE AND CHARACTERISTICS OF DELTA-8 THC USE IN U.S. ADULTS Okafor, Emeka

260 S p.
artikel
588 Prevalence and Correlates of Self-Reported Novel Psychoactive Substance Use Among Adults in 13 US Cities, 2021–2022: Results From National Drug Early Warning System (NDEWS) Surveillance Fitzgerald, Nicole

260 S p.
artikel
589 Prevalence, Geographic Variation and Racial/Ethnic Disparities in Methamphetamine Associated Heart Failure Among Veterans Manja, Veena

260 S p.
artikel
590 Prevalence of Cannabis, Nicotine, and Alcohol Use and Associations With Psychological and Diabetes Distress Among Young Adults With Type 1 Diabetes Plaitano, Enzo

260 S p.
artikel
591 Prevalence of Cannabis Use Disorder Among Primary Care Patients who Use Cannabis for Medical Only, Nonmedical Only, or Both Reasons Lapham, Gwen

260 S p.
artikel
592 Prevalence of Comorbid Substance Use Disorders Among People With Opioid Use Disorder: A Systematic Review and Meta-Analysis Santo, Thomas

260 S p.
artikel
593 Prevalence of Opioid Use Disorder and Overdose Rates Among People With Mental Illness in New York State Castillo, Felipe

260 S p.
artikel
594 Prevalence of Polysubstance Use Diagnoses in Electronic Health Records Data for Patients Hospitalized With Opioid Use Disorder or Opioid Poisoning at Six NYC Public Hospitals King, Carla

260 S p.
artikel
595 Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study Vidot, Denise

260 S p.
artikel
596 PREVALENCE OF PSYCHOSOCIAL ISSUES AMONG PREGNANT WOMEN WHO DO AND DO NOT USE ILLICIT SUBSTANCES Heil, Sarah

260 S p.
artikel
597 Prevalence of Secondary Health Diagnoses Among Persons Presenting in Texas Hospitals With an Opioid or Stimulant Diagnosis Compared to General Population Michael Wilkerson, J.

260 S p.
artikel
598 Primary Care Team Perspectives on Approaches to Engaging Patients in Treatment for Opioid Use Disorder Austin, Elizabeth

260 S p.
artikel
599 Primary Form of Cannabis Use and Recent Negative Affect Symptoms Cservenka, Anita

260 S p.
artikel
600 Profiles of Risk and Protection Among People who Use Illicit Opioids in NYC: A Latent Class Analysis Elliott, Luther

260 S p.
artikel
601 Prolonged Exposure Therapy for Individuals with Co-Occurring Posttraumatic Stress Disorder and Opioid Use Disorder: A Randomized Clinical Trial Peck, Kelly

260 S p.
artikel
602 Proof of Concept of Regional Oximetry to Detect Opioid Induced Respiratory Depression, Signifying Possible Overdose Hite, Desislava

260 S p.
artikel
603 Prospective Acceptability of Digital Phenotyping Among Pregnant and Parenting People With Opioid Use Disorder Charron, Elizabeth

260 S p.
artikel
604 Provider-Patient Alliance and Trauma Among Pregnant People With Opioid Use Disorder Angarita, Gustavo

260 S p.
artikel
605 Provider Perspectives on Facilitators and Barriers to Providing HIV Pre-Exposure Prophylaxis (PrEP) in Hospital-Based Addiction Treatment Bridge Clinics to Women Sex Workers who Use Drugs Harris, Miriam

260 S p.
artikel
606 Proximity to Low Barrier Resources for Alabamians Hospitalized With Injection Drug Use Gagnon, Kelly

260 S p.
artikel
607 Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps Henningfield, Jack

260 S p.
artikel
608 Psychiatrists’ Personal Use and Social Proximity to Psychedelics Predicts Attitudes Towards Drugs and Drug Users Levin, Adam

260 S p.
artikel
609 Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain Sweeney, Kaylin

260 S p.
artikel
610 PSYCHOSOCIAL FACTORS ASSOCIATED WITH PRENATAL MARIJUANA USE Boss, Nicole

260 S p.
artikel
611 Psychosocial Functioning and Health Service Utilization Among Psychiatric Subgroups in a Substance-Using Homeless Population: A Cluster Analysis of the at Home/Chez Soi Study in Vancouver, BC Chao, Thomas Wen-Chi

260 S p.
artikel
612 Puff Puff Pass: The Impact of Social Context on Momentary Subjective Cannabis Effects Bedillion, Margaret

260 S p.
artikel
613 Pupillometer to Predict Postoperative Opioid-Induced Respiratory Depression in Children Oliver, Jeffrey

260 S p.
artikel
614 Qualitatively Exploring Pharmacist and Patient Needs to Design a Patient-Centered Pharmacy-Based Opioid Misuse Screening and Brief Intervention Rao, Deepika

260 S p.
artikel
615 Racial Disparities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women With Opioid Use Disorder: An Analysis of Multi-State Insurance Claims in the USA (2006-2016) Xu, Kevin

260 S p.
artikel
616 Racial/Ethnic Differences in Treatment-Related Barriers and Facilitators Among Patients Initiating Medication for Opioid Use Disorder (MOUD) as Part of Comprehensive Patient Navigation Programs McCuistian, Caravella

260 S p.
artikel
617 RAE cHealth: A Digital Tool to Support Peer Recovery-Based Treatment for Substance Use Disorder and to Reduce Digital Inequity Carreiro, Stephanie

260 S p.
artikel
618 Randomized Controlled Trial Testing the Efficacy of a Remote Caffeine Reduction Intervention Lee, Dustin

260 S p.
artikel
619 Rapid Jail-Based Implementation of Overdose Education and Naloxone Distribution (OEND) in Response to the COVID-19 Pandemic Oser, Carrie

260 S p.
artikel
620 Rasagiline Protective Effect on Rotenone-Induced Neurotoxicity in Mice Assi, Abdelazim

260 S p.
artikel
621 Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics Kan, Emily

260 S p.
artikel
622 Readiness to Implement Contingency Management to Promote PrEP Initiation and Adherence Among People who Inject Drugs Viera, Adam

260 S p.
artikel
623 Realist Evaluation of the Impact, Viability, and Transferability of an Alcohol Harm Reduction Support Program Based on Mental Health Recovery: The Vitae Study: First Results Moriceau, Sarah

260 S p.
artikel
624 Reasons for Past Abortions Among Women in Treatment for Opioid Use Disorder Harfmann, Roxanne

260 S p.
artikel
625 Receipt of Prescribed Opioids and Benzodiazepines After Non-Fatal Overdose and Risk of Subsequent Overdose Howell, Benjamin

260 S p.
artikel
626 RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS Cook, Ryan

260 S p.
artikel
627 Recovery Support Services Research Priorities Developed by People With Lived Expertise Buell, Eden

260 S p.
artikel
628 Recreational Cannabis Legislation and Binge Drinking in U.S. Adolescents and Adults Between 2008-2019 Gonçalves, Priscila

260 S p.
artikel
629 Reduced Demand for Substances Following Visual Exposure to Natural Versus Built Stimuli Almog, Shahar

260 S p.
artikel
630 REDUCED SMOKING AND BEHAVIOR CHANGE MECHANISMS ASSOCIATED WITH A GENETICALLY-INFORMED SMOKING CESSATION INTERVENTION: A FULLY-REMOTE RANDOMIZED CONTROLLED TRIAL Ramsey, Alex

260 S p.
artikel
631 Reduce Return to Use: Personalized AI for Individuals in Recovery Gordon, Ellie

260 S p.
artikel
632 Reduction in Substance Use-Related Harms Among a Cohort of People Receiving Injectable Opioid Agonist Treatment in Ontario, Canada Mbichila, Tinkhani

260 S p.
artikel
633 Referral Appointment Wait-Times and Arrival for Patients Accessing Medication for Opioid Use Disorder (MOUD) in an Emergency Department (ED) Lane, Suzanne

260 S p.
artikel
634 Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022 Won, Nae

260 S p.
artikel
635 Relationship Between Blood THC and Metabolite Concentrations and Rapidly Collected and Analyzed Breath Samples in Heathy Volunteers After Smoking Marihuana Lukas, Scott

260 S p.
artikel
636 RELATIONSHIP BETWEEN INCREASED POLYSUBSTANCE USE, ANXIETY, AND STRESS DURING THE COVID-19 PANDEMIC: RESULTS FROM THE COVID-19 CANNABIS HEALTH STUDY Weerakoon, Sitara

260 S p.
artikel
637 Relationships Between Socioeconomic Position and Quitting Smoking Among Pregnant Women: A Longitudinal Assessment From Waves 1–5 of the Population Assessment of Tobacco and Health Study Kock, Loren

260 S p.
artikel
638 REMOTE CONTINGENCY MANAGEMENT FOR ALCOHOL USE DISORDER: RELATIONSHIP OF TREATMENT OUTCOMES TO INITIAL ABSTINENCE STATUS Strickland, Justin

260 S p.
artikel
639 Resilience as a Mediator of Amphetamine Dependence and Psychiatric Symptoms in Deferred Prosecuted Individuals who Use Amphetamine in Taiwan Hung, Chia-Chun

260 S p.
artikel
640 RESISTANCE OF COCAINE AND FOOD REINFORCEMENT TO EXTINCTION AND PUNISHMENT UNDER FIXED VS. VARIABLE SCHEDULES IN MALE AND FEMALE RHESUS MONKEYS Doyle, William

260 S p.
artikel
641 Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose Fantegrossi, William

260 S p.
artikel
642 RESPIRATORY DEPRESSING EFFECTS OF THE FLUORINATED FENTANYL ANALOGS, NFEPP, AND RR-49 Edwards, Shelley

260 S p.
artikel
643 Resting-State Electroencephalogram Markers of Sleep Quality in Cocaine Use Disorder Webber, Heather

260 S p.
artikel
644 Results From a Phase 2, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group Study of Sunobinop in Subjects who are Experiencing Insomnia During Recovery From Alcohol Use Disorder Sessler, Nelson

260 S p.
artikel
645 Results of Pilot Randomized Controlled Trial of Cognitive Behavioral Therapy for Insomnia to Reduce Cannabis Use Ilgen, Mark

260 S p.
artikel
646 RETENTION IN TELEHEALTH TREATMENT FOR OPIOID USE DISORDER AMONG PREGNANT PEOPLE Lira, Marlene

260 S p.
artikel
647 REWARD-ENHANCEMENT DRIVES NICOTINE SELF-ADMINISTRATION IN FEMALE SPRAGUE-DAWLEY RATS McNealy, Kathleen

260 S p.
artikel
648 REWARDING EFFECTS OF DELTA 8-TETRAHYDROCANNABINOL, CANNABIDIOL, AND A MIXTURE FOLLOWING OF VAPOR EXPOSURE IN MALE RATS Stairs, Dustin

260 S p.
artikel
649 Rising Solitary Cannabis Use Among Young Adults Over Time: Investigating Cannabis Practices, Motivations, and Demographic Factors Lankenau, Stephen

260 S p.
artikel
650 Risk Factors for Misuse Versus Abuse of Opioids and Sedatives Schow, Nicole

260 S p.
artikel
651 Role of Piriform Cortex and it's Afferent Projections in Relapse to Fentanyl Seeking After Food Choice-Induced Voluntary Abstinence Claypool, Sarah

260 S p.
artikel
652 Safety and Subjective Reinforcing Effects of Lorcaserin on Oxycodone in Adults With Opioid Use Disorder Ochalek, Taylor

260 S p.
artikel
653 Safety and Tolerability of Ascending Doses of ENA-001: A Novel Respiratory Stimulant, for the Intended Management of Pharmacologically-Induced Respiratory Depression Gould, Errol

260 S p.
artikel
654 SBI Tech Michigan: Optimizing Implementation of Screening and Brief Intervention for Excessive Alcohol Use Among Women of Reproductive Age Loree, Amy

260 S p.
artikel
655 Scaling up Opioid Agonist Therapies in Ukraine Before the War: Implementation Factors Related to Disruptions From Legislative Reform and COVID-19 Madden, Lynn

260 S p.
artikel
656 Screening for Co-Morbid OUD, PTSD, and Depression in a Primary Care Setting: Recruitment Results From a Randomized Clinical Trial Crowley, Christina

260 S p.
artikel
657 Screening for Opioid Use Disorder at Public Sexual Health Clinics Gryczynski, Jan

260 S p.
artikel
658 Screening Test for Drug Abuse Among Blood Donors in the West Bank, a Cross-Sectional Study Awad, Ashraf

260 S p.
artikel
659 SELECTIVE REDUCTION OF SOCIOECONOMIC DISPARITIES IN THE EXPERIMENTAL TOBACCO MARKETPLACE: EFFECTS OF CIGARETTE AND E-CIGARETTE FLAVOR RESTRICTIONS Freitas-Lemos, Roberta

260 S p.
artikel
660 Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication Bontemps, Andrew

260 S p.
artikel
661 Self-Reported Opioid Overdose via 120-Day Timeline Follow-Back and Documented Overdose Medical Encounters Among Opioid Overdose Survivors Smith, Rachel

260 S p.
artikel
662 Severity of Stimulant Use Disorder by Type of Stimulant Schepis, Ty

260 S p.
artikel
663 Sex and Age Differences in Suicide Attempts Among Opioid Overdose-Related 911 Dispatches McCabe, Andrew

260 S p.
artikel
664 Sex Differences Are Associated With Perceived Changes in Baseline and Post-Acute Religious Beliefs Among Ayahuasca Users Xin, Yitong

260 S p.
artikel
665 Sex Differences in Acute Pharmacological Stress-Induced Mood and Opioid-Seeking Behavior Moses, Tabitha

260 S p.
artikel
666 Sex Differences in Adversity and Risk for Future Alcohol Use in Youth in the ABCD Study Bounds, Dawn

260 S p.
artikel
667 Sex Differences in Cortical Thickness in Cannabis Use Disorder Martin, Erin

260 S p.
artikel
668 SEX DIFFERENCES IN EPIDEMIOLOGY RESEARCH ON NEWLY INCIDENT HEROIN USE AND SUICIDE ATTEMPTS Gregoire-Wallace, Villisha

260 S p.
artikel
669 SEX DIFFERENCES IN GABA REGULATION OF DOPAMINE RELEASE IN THE NUCLEUS ACCUMBENS AND ITS ROLE IN COCAINE USE DISORDER Christensen, Brooke

260 S p.
artikel
670 Sex Differences in Non-Fatal Overdose Rates: A Population-Based Administrative Health Records Study in British Columbia, Canada Marziali, Megan

260 S p.
artikel
671 Sex Differences in Prospective Trajectories of Alcohol but Not Marijuana Use Following Trauma Ellis, Robyn

260 S p.
artikel
672 SEX DIFFERENCES IN THE BEHAVIORAL PHARMACOLOGY OF FENTANYL IN RATS Little, Kaitlyn

260 S p.
artikel
673 Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months Yan, 'Elsie' Xu

260 S p.
artikel
674 Sex-Specific Associations Between Childhood Trauma and Tobacco Use Outcomes Palmisano, Alexandra

260 S p.
artikel
675 Sex Trafficking Experiences and Substance Use Patterns Among Incarcerated Women Who Use Opioids Tillson, Martha

260 S p.
artikel
676 Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting Kalmin, Mariah

260 S p.
artikel
677 Social Determinants of Health and Quality of Care Among Patients With Opioid Use Disorder Receiving Treatment in Rural Primary Care Settings Pham, Huyen

260 S p.
artikel
678 Social Role Protective Factors in Risky Substance Use Among a Community Sample of Emerging Adults Fenton, Melissa

260 S p.
artikel
679 Sociodemographic Correlates of a Substance-Related Diagnosis and Associations With the Number of Emergency Department Visits Using Electronic Health Record Data From 2012-2019 Kepner, Wayne

260 S p.
artikel
680 Sociodemographic Differences in Engagement With a Mobile Application to Support Recovery From Opioid and Stimulant Use Disorders in Missouri Szlyk, Hannah

260 S p.
artikel
681 Socioeconomic Marginalization and Overdose Risk: A Gender-Stratified Repeated Measures Latent Class Analysis Among Men and Women who Use Drugs Mitra, Sanjana

260 S p.
artikel
682 Socioeconomic Status and HIV Severity Among People With HIV who Inject Drugs in St. Petersburg, Russia Idrisov, Bulat

260 S p.
artikel
683 Socioeconomic Status Differences in U.S. Multiracial Adolescents’ Substance Use and Mental Health Problems Hai, Audrey

260 S p.
artikel
684 SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDER Pagni, Broc

260 S p.
artikel
685 State Cannabis Legalization and Changes in Cannabis Use as Determined by Biologic Testing in Emergency Department Patients in the U.S. Veterans Health Administration, 2008 to 2019 Fink, David

260 S p.
artikel
686 STATE CANNABIS LEGALIZATION AND INCREASES IN CANNABIS USE DISORDER IN THE U.S. VETERANS HEALTH ADMINISTRATION, 2005 TO 2019 Hasin, Deborah

260 S p.
artikel
687 State Laws Regulating Provision of Incentives Related to Substance Use Andraka-Christou, Barbara

260 S p.
artikel
688 State-Level Synthetic Opioid Arrests in the United States: Overall and Race-Specific Trends, 1990-2016 Annunziato, Erin

260 S p.
artikel
689 State Licensure Policy as an Innovative Tool for Mainstreaming Medications for Opioid Use Disorder Kennedy-Hendricks, Alene

260 S p.
artikel
690 Substance Co-Exposure Among Women With Opioid Use During Pregnancy Kuzniewicz, Michael

260 S p.
artikel
691 Substance Use in Pregnancy is Associated With Attention Deficit Hyperactivity Disorder in Childhood: Findings From the Adolescent Brain Cognitive Development Study Ryan, Jennie

260 S p.
artikel
692 Substance Use Patterns and Access to Services in Humanitarian Settings: A Formative Research Study Haddad, Stephanie

260 S p.
artikel
693 Substance Use Patterns and Impulsivity Among Bariatric Surgery Patients Arnold, Rachel

260 S p.
artikel
694 Substance Use, Psychiatric Disorders, and the COVID-19 Vaccine: A Quality Improvement Project Karavolis, Zoe

260 S p.
artikel
695 Substance Use Screening Rates and Screening Results Among Adult Primary Care Patients With Mental Health Conditions and Substance Use-Related Medical Conditions McNeely, Jennifer

260 S p.
artikel
696 Substance Use Stigma and Abstinence Self-Efficacy Among Justice-Involved Women Who Use Opioids Webster, Matt

260 S p.
artikel
697 Successful Integration of Care for Patients With Serious Injection-Related Infections and Substance Use Disorder in a Tertiary Care Hospital. Cooper, Clinton

260 S p.
artikel
698 Supportive Services Program Utilization Among Substance Use Treatment Clients Using Big Data Khalsa, Rama

260 S p.
artikel
699 SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS Illenberger, Jessica

260 S p.
artikel
700 SYMPOSIUM: A GENTLE INTRODUCTION TO DATA SCIENCE TOOLS FOR ADDICTION RESEARCH: USE CASES WITH EXAMPLES Odom, Gabriel

260 S p.
artikel
701 SYMPOSIUM: BEYOND GWAS: THE GENETICS AND EPIGENETICS OF ADDICTION Pollock, Jonathan

260 S p.
artikel
702 SYMPOSIUM: DEVELOPMENT OF FENTANYL-TARGETED VACCINES TO DECREASE OVERDOSE FATALITIES Townsend, Drew

260 S p.
artikel
703 SYMPOSIUM: DRIVING IMPAIRMENT CAUSED BY THE USE OF CANNABIS AND OTHER DRUGS: RECENT EVIDENCE FROM HUMAN LABORATORY STUDIES Spindle, Tory

260 S p.
artikel
704 SYMPOSIUM: DYSREGULATION OF THE PREFRONTAL CORTEX IN SUBSTANCE USE DISORDERS McGinty, Jacqueline

260 S p.
artikel
705 SYMPOSIUM: HOW NEUROIMAGING CAN BE USED IN TREATMENT DEVELOPMENT IN DRUG ADDICTION: FROM FDA STANDARDS TO CLINICAL APPLICATIONS Ekhtiari, Hamed

260 S p.
artikel
706 Symposium: In Memoriam Martin Adler Lukas, Scott

260 S p.
artikel
707 SYMPOSIUM: LEAVING NO ONE BEHIND: ENDING THE HIV EPIDEMIC WITH TARGETED INTERVENTIONS FOR PEOPLE WHO USE DRUGS Schmitz, Joy

260 S p.
artikel
708 SYMPOSIUM: MEASUREMENT OF CANNABIS CONSUMPTION TO DETERMINE RISK AND PROMOTE PUBLIC HEALTH Budney, Alan

260 S p.
artikel
709 SYMPOSIUM: NEUROPEPTIDES IN REWARD, ADDICTION, AND MENTAL HEALTH Ananthan, Subramaniam

260 S p.
artikel
710 SYMPOSIUM: NOT LIKE OTHER OPIOIDS: HOW IS FENTANYL UNIQUE? Dunn, Kelly

260 S p.
artikel
711 SYMPOSIUM: PREVENTION IS BETTER THAN CURE: EARLY INTERVENTION FOR SUBSTANCE USE DISORDERS Bedi, Gillinder

260 S p.
artikel
712 SYMPOSIUM: STIMULATION FOR THE TREATMENT OF STIMULANT USE DISORDER Foster, Katrina

260 S p.
artikel
713 SYMPOSIUM: THE INTERSECTION OF AGING, TOBACCO USE, AND HEALTH EQUITY Kleykamp, Bethea

260 S p.
artikel
714 SYMPOSIUM: THE INTERSECTION OF COVID-19 AND SUBSTANCE USE DISORDERS Blanco, Carlos

260 S p.
artikel
715 SYMPOSIUM: THE PAST, PRESENT, AND FUTURE OF REINFORCER PATHOLOGY THEORY IN SUBSTANCE USE DISORDER Strickland, Justin

260 S p.
artikel
716 SYMPOSIUM: THE POTENTIAL OF PSYCHEDELIC THERAPIES FOR SUBSTANCE USE DISORDERS Garcia-Romeu, Albert

260 S p.
artikel
717 SYMPOSIUM: THE RACIST ORIGINS AND IMPACT OF THE WAR ON DRUGS Adinoff, Bryon

260 S p.
artikel
718 SYMPOSIUM: TREATING SUD IN PATIENTS WITH PTSD AND HISTORIES OF VICTIMIZATION Mulford, Carrie

260 S p.
artikel
719 SYMPOSIUM: UNIVERSAL PRECAUTIONS: CONSIDERATIONS WHEN CONDUCTING CLINICAL ADDICTION RESEARCH IN THE ACUTE CARE HOSPITAL Lofwall, Michelle

260 S p.
artikel
720 SYMPOSIUM: USING BIG DATA TO UNDERSTAND THE ROLE OF THE GUT MICROBIOME IN SUBSTANCE USE DISORDERS Wright, Susan

260 S p.
artikel
721 SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS Huskinson, Sally

260 S p.
artikel
722 Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada Karamouzian, Mohammad

260 S p.
artikel
723 Take-Home Methadone Research From 2020 Through 2022: A Narrative Review Terashima, Javier Ponce

260 S p.
artikel
724 Targeting a Non-Opioid Signaling Pathway to Reverse Opioid-Induced Respiratory Depression Chang, Andy

260 S p.
artikel
725 TELEMEDICINE FOR UNHEALTHY ALCOHOL USE FOR ADULTS LIVING WITH HIV IN ALABAMA, USING COMMON ELEMENTS TREATMENT APPROACH (TALC) Levy, Sera

260 S p.
artikel
726 TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY Fedorova, Ekaterina

260 S p.
artikel
727 THC/CBD Vapor Self-Administration in Female Rats Results in Spatial Memory Deficits and Increases Methamphetamine Self-Administration Carter, Jordan

260 S p.
artikel
728 THE ACTIVE ALKALOID OF KRATOM ALONE AND IN COMBINATION WITH NALTREXONE SUPPRESSES OPERANT ALCOHOL SELF-ADMINISTRATION AND ALTERS CFOS EXPRESSION IN BRAIN REWARD REGIONS Haile, Colin

260 S p.
artikel
729 THE ACTIVITIES OF THE ENANTIOMERS OF A SLOW ONSET DOPAMINE REUPTAKE INHIBITOR Froimowitz, Mark

260 S p.
artikel
730 The Adolescent Path? Anhedonia and Cannavaping Use Ortiz, Cynthia

260 S p.
artikel
731 The Application of Positive Psychology to Substance Use, Addiction, and Recovery Research: An Updated Systematic Review Carlon, Hannah

260 S p.
artikel
732 The Association Between Psychosocial Syndemic Conditions and Chemsex Among Men who Have Sex With Men Seeking PrEP in Thailand Oon-arom, Awirut

260 S p.
artikel
733 The Association of Self-Report Adherence to Hepatitis C (HCV) Direct-Acting Antiviral (DAA) Therapy With Measured Adherence and Sustained Virologic Response Among People Who Inject Drugs (PWID) Receiving Opioid Agonist Therapy Lopes, Snehal

260 S p.
artikel
734 The ATTC Network: 30 Years of Supporting EBP Implementation in SUD Treatment and Recovery Services Henry, Maxine

260 S p.
artikel
735 THE BLINDED-DOSE PURCHASE TASK: ASSESSING HYPOTHETICAL DEMAND BASED ON COCAINE, METHAMPHETAMINE, AND ALCOHOL ADMINISTRATION Naudé, Gideon

260 S p.
artikel
736 The Computerized Oral Prescription Administration System (COPA™): An Innovative Hand-Held Oral Liquid Medication Dispensing Device With Remote Monitoring and Dual Biometrics With the Potential to Streamline Clinical Trials King, Thomas

260 S p.
artikel
737 THE CONSEQUENCES OF MATERNAL AND PATERNAL INCARCERATION ON ADOLESCENT ALCOHOL AND CANNABIS USE: ASSESSING RACIAL DIFFERENCES Moss, Shadiya

260 S p.
artikel
738 The Controlled Substances Act Regulations on Schedule I Researcher Registrations and the Need to Investigate New Substances of Abuse Carbonaro, Theresa

260 S p.
artikel
739 The Cost Effectiveness of Interim Buprenorphine Treatment vs. Waitlist Control for Opioid Use Disorder: An Analysis of Three Randomized Trials Batchelder, Sydney

260 S p.
artikel
740 The Creation of a Web-Based, Interactive, Cost-Effectiveness Calculator for Bystander Naloxone Distribution Programs Wang, Hannah

260 S p.
artikel
741 The Development of a Conceptual Model to Assess Intersectional Stigma’s Role in Shaping Rural Primary Care Providers’ Decisions to Implement Harm Reduction, Buprenorphine, and HIV Prevention Marotta, Phil

260 S p.
artikel
742 The Development of a Knowledge, Attitude, and Practice Questionnaire for Methamphetamine Use Azmi, Amirul Danial

260 S p.
artikel
743 The Dynamics of Craving and Willingness-to-Pay for Drugs and Food in Daily Life Grunevski, Sergej

260 S p.
artikel
744 THE EFFECTIVENESS OF A VOLUNTARY, PRE-ARREST, DRUG DIVERSIONARY PROGRAM IN LAKE COUNTY, IL Krause, Christopher A.

260 S p.
artikel
745 The Effect of Mental Illness on High-Risk Opioid Prescribing for Clients With Comorbid Pain and Alcohol Use Disorder in New York State Falls, Zackary

260 S p.
artikel
746 THE EFFECT OF NICOTINE ON COCAINE REINFORCEMENT IN A NONHUMAN PRIMATE MODEL OF COCAINE ABUSE Allen, Mia

260 S p.
artikel
747 The Effect of Opioid-Stimulant Co-Use on Tonic and Cue Induced Cravings Hochheimer, Martin

260 S p.
artikel
748 The Effect of Prolonged Exposure Therapy on Posttraumatic Stress Disorder Symptom Clusters in Individuals With Opioid Use Disorder Giannini, Jillian

260 S p.
artikel
749 THE EFFECTS OF CANNABICHROMENE (CBC) ON CISPLATIN-INDUCED NEUROPATHY AND REWARD IN MICE Harris, Hannah

260 S p.
artikel
750 THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA Ewart, Leah

260 S p.
artikel
751 The Growth Hormone Secretagogue Receptor Inverse Agonist/Antagonist PF5190457 Suppresses Fentanyl Intake and Seeking in Rats Anastasio, Noelle

260 S p.
artikel
752 The Impact and Evolution of Structural Vulnerabilities Throughout Substance Use Initiation, Treatment, and Recovery: Perspectives From Providers and Women With Opioid Use Disorder Harrison, Eric

260 S p.
artikel
753 The Impact of CDC’s Opioid Prescribing Guideline on Racial Disparities in Discontinuation of Opioid Treatment in the United States Dong, Huiru

260 S p.
artikel
754 THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN Ray, Azizi

260 S p.
artikel
755 The Impact of Heroin Self-Administration on CRF1 and CRF2 Expression Within the Nigrostriatal and Mesocorticolimbic Systems Galaj, Ewa

260 S p.
artikel
756 The Impact of Tobacco Use on Liver-Related Morbidity in Patients With Cirrhosis Haque, Lamia

260 S p.
artikel
757 The Impact (or Lack Thereof) of Moving to Remote Study Procedures on Quit Attempts in an NRT Sampling Intervention Hawes, Elizabeth

260 S p.
artikel
758 THE IMPORTANCE OF THE PERIRHINAL CORTEX TO THE NUCLEUS ACCUMBENS CIRCUIT FOR NOVELTY DISCRIMINATION IN METHAMPHETAMINE SELF-ADMINISTERING RATS Nelson, Katharine

260 S p.
artikel
759 THE INFLUENCE OF E-CIGARETTE REDUCTION ON COMBUSTED CIGARETTE SMOKING AMONG DUAL USERS: A PILOT RANDOMIZED CONTROLLED TRIAL Klemperer, Elias

260 S p.
artikel
760 The Influence of Intraoperative Opioid Administration on Postoperative Pain and Opioid Requirements Mercado, Laura Santa Cruz

260 S p.
artikel
761 The Interaction Between Anhedonia and Impulsivity in Opioid Use Disorder Kouri, Nicole

260 S p.
artikel
762 The Interplay of Temporal Contexts With Social and Physical Contexts on Alcohol and Marijuana Use and Related Consequences Arterberry, Brooke

260 S p.
artikel
763 The Left Dorsolateral Prefrontal Cortex Modulates the Perception of Low Dose THC Effects in Individuals With Problematic Cannabis Use Ramirez, Miranda

260 S p.
artikel
764 The NIDA Cause of Death Elucidated (CODE) Initiative: Developing Innovative Postmortem Toxicology Testing Devices to Reduce the Undercounting of Drug Overdose Deaths Nguyen, Tam

260 S p.
artikel
765 THE NOCICEPTIN RECEPTOR ANTAGONIST LY2940094 SUPPRESSES OPIOID SELF-ADMINISTRATION IN MALE RATS Chapman, Holly

260 S p.
artikel
766 The Pharmacist-Integrated Medication Treatment for Opioid Use Disorder (PrIMO) Model: Operationalizing an Effective Clinical Care Model to Assess Feasibility in Diverse Care Settings Homsted, Felicity

260 S p.
artikel
767 The Potential Moderating Effects of Alcohol Use Severity and Reinforcer Valuation on Suicidal Thoughts and Behaviors Rzeszutek, Mark

260 S p.
artikel
768 The Potential of Virtual Reality to Treat Substance Use Disorders Clingan, Sarah

260 S p.
artikel
769 The PRimary Care Opioid Use Disorders Treatment (PROUD) Trial Wartko, Paige

260 S p.
artikel
770 The Relationship Between High-Potency Cannabis Use and Health-Related Factors: A Systematic Review of Experimental and Observational Studies Lake, Stephanie

260 S p.
artikel
771 The Relationship Between Medical and Recreational Cannabis Legalization With Opioid Misuse Among Individuals Reporting Medically Recommended Cannabis Use Martins, Silvia

260 S p.
artikel
772 The Relationship Between Substance Use and Remote HIV Testing Among Men at Risk for HIV McLeman, Bethany

260 S p.
artikel
773 The Role of Law Enforcement Officers in Overdose Response: Insights From a Qualitative Study With People who Use Drugs and Law Enforcement Officers Silverstein, Sydney

260 S p.
artikel
774 The Role of Past Substance Use on ART Adherence Among Black People With HIV Serrano, Vanessa

260 S p.
artikel
775 The Substance Abuse Self-Stigma Scale: Reliability Among Veterans With Co-Occurring Chronic Pain and Opioid Use Disorder Joseph, Verlin

260 S p.
artikel
776 The Use of LSD by Major Depression Status in the U.S.: 2008-2019 Time Trends and Sociodemographic Associations Walsh, Claire

260 S p.
artikel
777 The Vox Venturi Device: Portable Breath-Based THC and Opioid Detection Golde, Jake

260 S p.
artikel
778 They Don’t Care who you are, They’re Only There to Help you: Barriers and Facilitators to Accessing Syringe Service Programs (SSPs) Among People who Inject Drugs (PWID) in Appalachia Ohio Endres-Dighe, Stacy M.

260 S p.
artikel
779 TIME-VARYING EFFECTS OF SUBSTANCE CRAVING ON SUBSTANCE USE AMONG PREGNANT WOMEN IN SUBSTANCE USE DISORDER TREATMENT Schwebel, Frank

260 S p.
artikel
780 Tobacco Use and Sleep Problems in the Population Assessment of Tobacco and Health (PATH) Study Hansson, Jocelyn

260 S p.
artikel
781 Toward a More Complete Comparative Epidemiology of Heroin Use: Female-Male Variations in Using Once and Only Once Montgomery, Barrett

260 S p.
artikel
782 Towards the Understanding of Smoking Reduction in a Home Use Test Paradigm Cheng, Hui

260 S p.
artikel
783 Toxicology Testing Inequities During the Birthing Hospitalization and Impact of an Institutional Intervention Habersham, Leah

260 S p.
artikel
784 Trajectories of Substance Abuse Treatment Usage: A 9-Year Longitudinal Approach Using Latent Class Growth Analysis and Multichannel Sequence Analysis Borquez, Ignacio

260 S p.
artikel
785 TRANSCRANIAL DIRECT CURRENT STIMULATION TREATMENT IN PATIENTS WITH ALCOHOL DEPENDENCE: A RANDOMIZED SHAM-CONTROLLED TRIAL Lin, Pei-Hsuan

260 S p.
artikel
786 Transcultural Translation and Adaptation of the Universal Treatment Curriculum for Fostering Professional Treatment Workforce for Substance Use Disorders in Taiwan Chung, An-Nie

260 S p.
artikel
787 Transcutaneous Auricular Neurostimulation (tAN): An Emerging Treatment Strategy to Combat the Opioid Crisis Khodaparast, Navid

260 S p.
artikel
788 Transgenerational Effects of Parental Fentanyl Dependence on Sleep and Cognition During Adolescence Jones, Marissa

260 S p.
artikel
789 Transition Strategies to Link Patients With Substance Use Disorders From Acute Care to Community-Based Treatment Settings: A Scoping Review Krawczyk, Noa

260 S p.
artikel
790 Transition to Antagonist Treatment in the Age of Fentanyl Woody, George

260 S p.
artikel
791 Trauma and Craving Among Those Reentering From the Criminal Justice System With Opioid Use Disorder: Treatment Implications Fendrich, Michael

260 S p.
artikel
792 Trauma-Related Shame Predicts Daily Non-Medical Prescription Opioid Use and Motives for Use Among Individuals with PTSD Saraiya, Tanya

260 S p.
artikel
793 Traumatic Events, Chronic Pain, and Multiple Substance Use in Women With Poly-Substance Use Disorder Fogelman, Nia

260 S p.
artikel
794 Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users Jerome Feinstein, Marc

260 S p.
artikel
795 Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement Loya, Jennifer

260 S p.
artikel
796 TREATMENT-RELATED CHANGES IN THE TEMPORAL DYNAMICS OF RESTING-STATE BRAIN ACTIVATION IN NICOTINE-DEPENDENT INDIVIDUALS Wanger, Timothy

260 S p.
artikel
797 Treatment Setting Among Individuals With Opioid Use and Criminal Legal Involvement, Housing Instability, or Medicaid Insurance, 2015-2020 Shearer, Riley

260 S p.
artikel
798 Trends in Buprenorphine Dosage and Days Supplied for New Treatment Episodes, 2010-2019 Tilhou, Alyssa

260 S p.
artikel
799 Trends in Buprenorphine Prescribing in a National Network of Community Health Centers Hartung, Daniel

260 S p.
artikel
800 Trends in Past-Month Alcohol and Tobacco Co-Use Among Older Adults in the US Between 2002-2019 Mauro, Pia

260 S p.
artikel
801 Trends in Prevalence of Cannabis Use Disorders Among U.S. Veterans With Psychiatric Disorders Between 2005 and 2019 Livne, Ofir

260 S p.
artikel
802 Trends in the Co-Use of Cannabis and Prescription Psychotherapeutic Drugs in the United States Elbaz, Hosam

260 S p.
artikel
803 Trends in Use of Prescribed “Safer Supply” Opioids Among People Living with HIV and Opioid Use Disorder in Vancouver, Canada Coll, Neasa

260 S p.
artikel
804 Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes Jones, Joseph

260 S p.
artikel
805 Understanding Cannabis Use Among Teens who Vape Nicotine Davis, Danielle

260 S p.
artikel
806 Understanding Ketamine Use in Treatment-Seeking Persons With Opioid Use Disorder Chandler, Corinne

260 S p.
artikel
807 Understanding the Needs of Women in Treatment for Opioid Use Disorder to Inform the Development of a Gender-Specific Digital Intervention Sugarman, Dawn

260 S p.
artikel
808 Unmet Social Gender Affirmation as a Driver of Drug Use Among Transgender Women: The Need for Policy and Protections Glynn, Tiffany

260 S p.
artikel
809 Untargeted Umbilical Cord Testing to Detect Novel Psychoactive Substances Smid, Marcela

260 S p.
artikel
810 USE OF CLUSTER ANALYSIS TECHNIQUES TO EXPLORE ICD-10-CM CODE DATA IN A LONGITUDINAL BIRTHING PERSON-CHILD LINKED SURVEILLANCE SYSTEM OF PREGNANCIES COMPLICATED BY OPIOID USE DISORDER Board, Amy

260 S p.
artikel
811 USING A CASCADE OF CARE FRAMEWORK TO IDENTIFY GAPS IN ACCESS TO MEDICATIONS FOR ALCOHOL USE DISORDER IN BRITISH COLUMBIA, CANADA Eugenia Socias, M.

260 S p.
artikel
812 Using an Environmental Scan to Organize Substance Use Prevention Resources to Address the Social Determinants of Health Hagle, Holly

260 S p.
artikel
813 USING BEHAVIORAL ECONOMICS TO QUANTIFY HOW PEOPLE WHO USE COCAINE RESPOND TO FENTANYL ADULTERATION Nunez, Cecilia

260 S p.
artikel
814 Using Biomarker Ratios to Distinguish Between Exclusive and Dual Use of Cigarettes, Smokeless Tobacco, and e-Cigarettes Edwards, Kathryn

260 S p.
artikel
815 Using Implementation Facilitation to Implement Interim Methadone in Opioid Treatment Programs Mitchell, Shannon

260 S p.
artikel
816 Using MegaSyn Generative Machine Learning to Identify Psychoplastogens for Opioid Abuse Treatment Harris, Joshua

260 S p.
artikel
817 Using Self-Reported Hits and Grams to Estimate Cannabis Consumption in Milligrams of THC Habib, Mohammad

260 S p.
artikel
818 Using Spatial Social Network Analysis to Study the Journey to Overdose Deaths Masoud Forati, Amir

260 S p.
artikel
819 Utilization of Medication for Opioid Use Disorder for Hospitalized Patients at 6 New York City Public Hospitals With an Addiction Consultation Service Abadi, Yasna Rostam

260 S p.
artikel
820 Valid and Invalid Designs for Conducting Drug-Discrimination Experiments in Abuse Potential Evaluations Heal, David

260 S p.
artikel
821 Variation in Psychosocial Symptom Change: A Preliminary Examination of Veterans in Early Medication Treatment for Opioid Use Disorder Wolkowicz, Noah

260 S p.
artikel
822 Ventilatory Effects of Fentanyl, Heroin, and D-Methamphetamine, Alone and in Mixtures, in Male Rats Hiranita, Takato

260 S p.
artikel
823 Vitamin D Deficiency in a Series of Heavy Drinkers Admitted for Hospital Treatment Fuster, Daniel

260 S p.
artikel
824 Vulnerability to Hyperalgesia and Hyperkatifeia Drives Addiction-Like Behaviors Marchette, Renata

260 S p.
artikel
825 Wearable Immunosensor Array for Rapid Opioids Detection levitsky, igor

260 S p.
artikel
826 What Makes an Emergency Department Peer? Characteristics of Effective Peer Recovery Support Specialists in an Ed-Based Post-Overdose Intervention Kirk, Mia

260 S p.
artikel
827 When a Prophecy Comes True: Ethyleneoxynitazene as a 'Prophetic' Member of the Emerging Class of 2-Benzylbenzimidazole 'Nitazene' Synthetic Opioids Vandeputte, Marthe

260 S p.
artikel
828 WHEN BEST PRACTICES FAIL: NUANCES OF USING NARRATIVES IN DISSEMINATING SUBSTANCE USE RESEARCH TO POLICYMAKERS Long, Elizabeth

260 S p.
artikel
829 White Matter Structural Organization Alterations in People Living With HIV With Heavy Cannabis Use Bell, Ryan

260 S p.
artikel
830 WITHIN-SUBJECT, DOUBLE-BLIND HUMAN LABORATORY EVALUATION OF CANNABIDIOL ON OPIOID-INDUCED ANALGESIA AND SUBJECTIVE EFFECTS Bergeria, Cecilia

260 S p.
artikel
831 Within-Subject Variations in Opioid Sensitivity Across Patient-Reported Outcomes, Observer-Ratings, Physiological Endpoints, and Analgesic Responses Durgin, Caitlyn

260 S p.
artikel
832 Women and Medications for Opioid Use Disorder: Contributors to Treatment Success From the Perspectives of Women in Recovery, Women With Past Attempts in Drug Treatment, and Health and Criminal Justice Professionals Skogseth, Emma

260 S p.
artikel
833 WORKING MEMORY ALTERATIONS PREDICT ADOLESCENT E-CIGARETTE USE AND POSITIVE OUTCOME EXPECTANCIES VIA ALEXITHYMIA Sutherland, Benjelene

260 S p.
artikel
834 WORKSHOP: A VIEW BEYOND THE HORIZON: INNOVATIVE METHODOLOGIES AND APPROACHES IN SUBSTANCE USE DISORDER RESEARCH AND TREATMENT UTILIZED INTERNATIONALLY Brandt, Laura

260 S p.
artikel
835 WORKSHOP: COLLABORATION AND COMPLICATION: LESSONS LEARNED IN IMPLEMENTING COMMUNITY-ENGAGED RESEARCH ON SUBSTANCE USE Banks, Devin

260 S p.
artikel
836 WORKSHOP: EARLY CAREER MEMBER COMMITTEE: NAVIGATING A CAREER IN ADDICTION SCIENCE Davis, Danielle

260 S p.
artikel
837 WORKSHOP: EPIDEMIOLOGY AND PUBLIC HEALTH RESEARCH METHODS Chilcoat, Howard

260 S p.
artikel
838 WORKSHOP: EVALUATING PENNSYLVANIA'S CENTERS OF EXCELLENCE ON IMPROVING OUD TREATMENT ACCESS & PATIENT CARE Cloutier, Renee

260 S p.
artikel
839 WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH Kathleen Burlew, A.

260 S p.
artikel
840 WORKSHOP: PATHWAYS TO RECOVERY AND BEYOND IN NATIVE AMERICAN COMMUNITIES Skinstad, Anne

260 S p.
artikel
841 WORKSHOP: "PRE-ADDICTION:" A STARTING POINT FOR A STRATEGIC SHIFT TOWARD EARLIER INTERVENTION IN SUBSTANCE USE DISORDERS Volkow, Nora

260 S p.
artikel
842 WORKSHOP: R/ASKACADEMIA: SPECIAL CONSIDERATIONS IN THE PRACTICE OF USING REDDIT FOR SUBSTANCE USE RESEARCH Brenneke, Savannah

260 S p.
artikel
843 WORKSHOP: SHARING YOUR SCIENTIFIC STORY: TIPS AND TRICKS FOR STRATEGICALLY AND EFFECTIVELY COMMUNICATING YOUR RESEARCH Evans, Rachel

260 S p.
artikel
844 WORKSHOP: STANDARDS OF PSYCHEDELIC CARE: PEER & PROFESSIONAL PROVIDERS Anderson, Brian

260 S p.
artikel
845 WORKSHOP: STRESSFUL ENVIRONMENTS AND GENETIC RISK FACTORS ASSOCIATED WITH EARLY INITIATION OF ALCOHOL AND SUBSTANCE USE: FINDINGS FROM THE ABCD STUDY Gonçalves, Priscila

260 S p.
artikel
846 WORKSHOP: 29TH ANNUAL CONTINGENCY MANAGEMENT WORKING GROUP Novak, Matthew

260 S p.
artikel
847 XYLAZINE: AN ADULTERANT DRUG OF CONCERN Calderon, Silvia

260 S p.
artikel
848 XYLAZINE REDUCES INTRAVENOUS FENTANYL CONSUMPTION BUT DOES NOT IMPAIR LEVER DISCRIMINATION IN MALE AND FEMALE RATS Khatri, Shailesh

260 S p.
artikel
849 You Can See that the Culture is Definitely Changing: Peer-Facilitated Telemedicine Hepatitis-C Treatment for People who Use Drugs Hoffman, Kim

260 S p.
artikel
                             849 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland